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ABSTRACT
Glycerophospholipids, or phospholipids, are important biochemical 
components of many biological organisms. They are involved in many biochemical 
processes including signal transduction, serving as enzyme substrates for lipoprotein 
metabolism and serving as ligands for receptors and precursors of essential 
biomolecules; they are also intracellular traffickers of cholesterol as well as 
modulators of the immune system. Likely to fulfill these diverse functional roles, not 
only do phospholipids contain a variety of head groups attached to a glycerol 
backbone but even more diversity exists within the fatty acyl chain(s) that are 
attached to the same glycerol backbone. These differences can be very subtle as is 
the case with phospholipid sn-positional isomers or double bond positional isomers, 
where the position of the acyl chain(s) attached to the glycerol backbone or the 
double bond position(s) within these acyl chains can vary only slightly but have 
vastly different biochemical consequences. Despite this, little is known about the 
abundances, let alone the biochemical or evolutionary reasons for the existence of 
these phospholipid isomers in different biological tissues. This paucity of information 
exists, in part due to the lack of methods that are both specific and sensitive enough 
to be used to detect and quantify these phospholipid isomers [and others], especially 
in complex biological extracts. To this end, this thesis describes the development of a 
number of new analytical workflows that combine ozone-induced dissociation with 
analytical separations and direct desorption/ionization technologies for the rapid 
identification of isomeric lipids. The methods developed and described herein have 
combined liquid chromatography (LC) and desorption electrospray ionization (DESI) 
with ozonolysis and collision induced dissociation (CID) to develop LC-OzID, LC- 
CID/OzID and DESI-CID/OzlD. This LC-OzID method has proven successful for the 
separation, identification and, to an extent, the quantification, of a number of 
phospholipid double bond positional isomers in complex biological samples. In a 
similar way, the LC-CID/OzID method described herein has proven successful for the 
separation and identification and to an extent, quantification, of several 
phospholipid sn-positional isomers. DESI-CID/OzlD has proven a successful
technique for the rapid identification and detection of relative differences in 
phospholipid sn-positional isomer composition in complex biological extracts 
spotted on a surface but also sampled directly from tissue. Experimental results from 
DESI-CID/OzlD experiments also support the likelihood that both complementary 
phospholipid sn-positional isomers are always present but at varied ratios in different 
tissues. Preliminary imaging data using DESI-CID/OzlD demonstrate the great 
potential of this technique for imaging variations in phospholipid sn-positional 
isomer composition across different regions of a biological tissue.
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ABBREVIATIONS
CID Collision-induced dissociation
DESI Desorption electrospray ionization
ESI Electrospray ionization
GC Gas chromatography
HILIC Hydrophilic interaction chromatography
HPLC High-performance liquid chromatography
LC Liquid chromatography
MALDI Matrix assisted laser desorption ionization
MS Mass spectrometry
MS/MS Tandem mass spectrometry
MSn Tandem mass spectrometry
m/z Mass-to-charge ratio
NP Normal phase
OzID Ozone-induced dissociation
PC Phosphatidylcholine
sn Stereospecific number
TIC Total ion chromatogram
TLC Thin layer chromatography
XIC Extracted ion chromatogram
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1 INTRODUCTION
1.1 Importance of Phospholipid Structure to Biochemical Function
Lipids in the average diet are primarily composed of triglycerides (TG) but also 
contain ca. 10% phospholipid content, which is largely comprised of 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE). Shown in Figure 1,1, 
are the general structures of PC, PE and the five other major phospholipid classes, 
organized by headgroup: phosphatidyl inositol (PI); phosphatidylserine (PS); 
phosphatidylglycerol (PG); phosphatidic acid (PA); and sphingomyelin (SM).
Glycerophospholipid
R,
Lysoglycerophospholipid
R2
Sphingomyelin
Figure 1.1 General Structures of Major Phospholipid Classes.
The general structure of major phospholipid classes. Phospholipids consist of a polar, 
hydrophilic head group, one or two hydrophobic acyl chain tail(s) and either a 
glycerol backbone, for glycerophospholipids, or a sphingosine backbone, in the case 
of sphingomyelin. The sites of acyl chain attachment are indicated by an R group -  
either R or Ri and R2 if two acyl chains are present. These acyl chain R groups usually
12
consist of a chain of carbon atoms that are either ester-linked or ether-linked to the 
glycerol backbone and may or may not include double bonds. In cases where two 
acyl chains are present, Ri and R2 can either represent the same acyl chain or different 
acyl chains. ^Additional phosphate group(s) may be located at these locations of the 
inositol head group. This figure was adapted from a previous publication.1
Phospholipids are complex lipids that contain a headgroup, linked by a 
phosphate ester, in addition to one (lysophospholipid) or two (diacylphospholipid) 
acyl chains attached to a glycerol backbone. Thus they contain both a hydrophobic 
tail region and a hydrophilic head region. These structural characteristics are 
essential for their role as components of cell membranes -  as they arrange into 
phospholipid bilayers w ith their hydrophobic tails facing each other and their 
hydrophilic head groups facing outwards towards the intra- and extra-cellular 
aqueous environments. Phospholipids also play an important role in nutrition and 
signal transduction for the maintenance and metabolic regulation of living cells.2 For 
example, they serve as ligands for receptors, enzyme substrates for lipoprotein 
metabolism, second messengers in signal transduction, precursors of essential 
biomolecules, intracellular traffickers of cholesterol as well as modulators of the 
immune system.3' 4 Individual phospholipid classes have also been associated with 
distinct biological effects. In studies in rabbits and rats, PC has been shown to 
enhance secretion of bile cholesterol and reduce both lymphatic cholesterol 
absorption and hepatic fatty acid synthesis.5-7 Also in rats, PE and its head group 
base, ethanolamine, were linked to increased excretion of neutral steroids, such as 
cholesterol, in fecal matter, resulting in a cholesterol-lowering effect.8' 9 In both 
rabbits and humans, phosphatidyl inositol was shown to increase levels of beneficial 
high density lipoprotein (HDL)-cholesterol.10' 11 Not only have distinct phospholipid 
classes been associated with important biological functions but so have individual 
phospholipids within a class.12 Such examples have led to a renewed interest in more 
fully elucidating the molecular structure of lipids in complex biological extracts and 
the evolution of a structural hierarchy classification. An example of the different 
levels of structural definition for a single given phospholipid structure (1- 
hexadecanoyl-2-(5Z, 8Z, 11Z, 14Z-eicoosatetraenoyl)-sn-glycero-3-phospho-L-serine)
13
is shown in Figure 1.2. Naming conventions at each level of structural description 
were taken from the IUPAC IUBMB Joint Commission on Biochemical Nomenclature 
and the suggestions of Fahy etal. and Liebisch et a/.1314
14
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Figure 1.2 Phospholipid Structural Hierarchy
The structure o f 1-hexadecanoyl-2~(5Z,8Z,11Z,14Z-eicoosatetraenoyl)-sn-glycero-3- 
phospho-L-serine and the structural classification groups relevant to it are shown.
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Under each of these structural classes is the name for the level of known structure 
taken either from recommendation of IUPAC or from Liebisch ef a/.13,15 if only a partial 
structure is known. The portions of the phospholipid structure that have changed 
from one structural class level to the next are highlighted in blue.
As increased structural information is obtained from different analytical 
technologies, the molecular structure of phospholipids can be more explicitly 
defined and thus further classified according to the hierarchy of nomenclature 
shown in Figure 1.2. Moving from top to bottom of this figure, increased structural 
information obtained decreases the number of possible structures. Within a 
phospholipid headgroup class, phospholipids may be further grouped according to 
the sum composition of all fatty acids attached. For instance, within the 
glycerophosphatidylserine class (PS), this can be described as PS 36:4 - containing 
any combination of fatty acids w ith a combined total of 36 carbons and 4 double 
bonds. One possible fatty acid combination of PS 36:4, is PS 16:0__20:4 where the acyl 
chains comprise a 16-carbon saturated and a 20-carbon polyunsaturated substituent. 
The regiospecificity of the attachment of 16:0 and 20:4 chains to the glycerol 
backbone can then be defined. Thus, PS 16:0/20:4 is a sub-class of PS 16:0_20:4 
meaning that 16:0 and 20:4 are found at the sn-1 and sn-2 position of the glycerol 
backbone, respectively, with the headgroup assumed to be at the sn-3 position. It 
should be noted, however, that w ithout information about the absolute 
stereochemistry of the chiral centre on the glycerol backbone, the assumption that 
the headgroup is at the sn-3 position may not be correct. Knowledge of the double 
bond positions within the unsaturated acyl chain, enables the lipid to be described 
as PS 16:0/20:4 (5,8,11,14) -  where the double bonds are said to be located at the 5th, 
8th, 11th and 14th carbon (as counted from the ester end) of the fatty acid. 
Alternatively, the double bond position may be labelled by counting from the methyl 
end and placing the number of the first carbon involved in the double bond within 
brackets directly preceded by "n-" such that PS 16:0/20:4 (5,8,11,14) and PS 16:0/20:4 
(n-6,n-9,n-12,n-15) would be structurally equivalent. The latter nomenclature will be 
used in Chapters 2 -  4 of this text and is otherwise noted elsewhere. The next 
possible level of molecular description is PS 16:0/20:4 (5Z,8Z,11Z,14Z) that explicitly
16
assigns the stereochemical configuration of all four double bonds as c/s in this case. 
Lastly, the stereochemistries of the chiral centres present in the phospholipid are 
defined in the final sub-class, 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn- 
glycero-3-phospho-i.-serine, which describes a single, unique molecular species.
These structural naming conventions arose from a growing need to more 
accurately identify specific levels of structural detail in order to incrementally 
strengthen the correlations between the phospholipid structural compositional 
differences and differences in other sample properties and the resultant 
conclusions.16 This need is especially important when attempting to pinpoint 
biochemical differences and/or biological effects arising from subtle structural 
differences in a small subset of phospholipids - such as the position(s) of the acyl 
chain(s) on the glycerol backbone or the position(s) of the double bond(s) along the 
acyl chain(s). These seemingly minor structural differences have already been linked 
to detectable physicochemical and functional differences in biological systems as 
discussed further in Chapters 2 - 4.
Lipids with similar structures, indeed even isomers, that share identical 
elemental composition, have been associated with vastly different physiological 
outcomes. For instance, it is generally believed that fatty acid precursors with the 
final double bond at the n-6 position (often referred to as u)-6) are associated with 
chronic inflammatory effects while to-3 fatty acid precursors are associated with 
resolving (anti-inflammatory) effects. These functional differences arise from subtle 
structural distinctions between lipid isomers that can be difficult to detect by 
modern analytical methods and are discussed in more detail in chapters 2 - 4 .  The 
structure of a biomolecule, e.g, a phospholipid, can provide significant insight into its 
biochemical function. It is therefore important to work towards complete structural 
elucidation in order to understand the distinct roles of very similar, yet structurally 
distinct, phospholipid isomers. Of concern to the studies outlined herein are double 
bond positional isomers and sn-positional isomers of phospholipids. Examples of 
each are shown in Figure 1.3.
17
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Figure 1.3 Phospholipid double bond positional isomers and sn-positional isomers.
The structures of a set of phospholipid double bond positional isomers and 
phospholipid sn-positional isomers are shown. Highlighted in green, the top and 
middle structures represent a pair o f phospholipid double bond positional isomers. 
The topmost structure has a single double bond [named as being] at the 11th carbon 
{although, technically speaking, this double bond involves both the 11th and the 12th 
carbon) in the 18:1 acyl chain at the sn-2 position. For the middle structure, PC 
16:0/18:1, the difference is the position of the double bond, named as belonging to 
the 9th carbon atom in the 18:1 acyl chain at the sn-2 position. Alongside the top 
structure, PC 16:0/18:1 (11Z), the carbon numbers of the acyl chain at the sn-2 
position are labelled. For the middle structure, PC 16:0/18:1 (9Z), the sn-positions of 
the glycerol backbone are labelled. The middle and bottom structures, highlighted in 
blue, are an example of a pair of phospholipid sn-positional isomers. In the middle 
structure, the 18:1 (9Z) acyl chain is located at the sn-2 position and the acyl chain, 
16:0, is located at the sn-1 position. For the bottom structure, this order is reversed so 
that the 18:1 (91) acyl chain is located at the sn-1 position while the 16:0 acyl chain is 
at the sn-2 position.
The top and middle phospholipid structures of Figure 1.3 are examples of a pair of 
phospholipid double bond positional isomers. At the top of this figure, PC 16:0/18:1 
(11Z) is shown and in the middle, PC 16:0/18:1 (9Z). The difference in these two 
structures is the location of the double bond along the acyl chain - located between 
the 11th and 12th carbon and the 9th and 10th carbon, respectively. The carbon atoms
18
are labelled, in this way, on PC 16:0/18:1 (11Z) in Figure 1.3. The middle and bottom 
structure, PC 16:0/18:1 (9Z) and PC 18:1 (9Z)/16:0, respectively, are an example of a 
pair of sn-positional isomers. The stereochemical numbering of the carbon atoms of 
the glycerol backbone is presented on the middle phospholipid structure, PC 
16:0/18:1 (9 Z).
As more phospholipid structural detail is obtained, more confident 
conclusions about their functions may be ascertained. In order to better understand 
the different biological functions associated w ith specific phospholipid structural 
features, it is first important to develop technologies with the power to accurately 
identify (and quantify) these distinct phospholipid isomers in complex biological 
samples. This need has stemmed from the ever-growing pool of scientific research 
correlating phospholipid structural differences to biological differences and/or 
functional differences.17 A deeper understanding of the importance of meeting the 
growing need for improved structural identification methods for phospholipids can 
be gained through a historical examination of phospholipid structural analysis.
1.2 Identification of Phospholipids
1,2.1 Elucidation of the General Structure of the First Phospholipid
Shortly after its discovery by Theodore Gobley, "lecithine" was defined in the 
mid 19th century as a phosphorus substance found within blood, chicken egg yolks 
and carp eggs that yielded oleic acid, margaric acid and phosphoglyceride upon 
decomposition with acid.18 By the early 20th century, lecithin had developed a 
reputation as a "peculiar complex body” found in many biological tissues including 
vegetables, brain, nerve, blood, lymph, milk and pus, but most readily prepared from 
egg yolk.19 Based on the widespread distribution of lecithin in many different 
biological samples as well as its occurrence in milk, it was assumed that lecithin 
played an important role in the body, and so the structure of lecithin quickly became 
a topic of interest for decades to fo llow .19 Initially, elemental analyses of lecithins 
were performed in addition to testing the products of acid hydrolysis and/or 
saponification of phosphatides for functional groups. However, important structural 
details, for instance the way glycerol was bound to either two oleic, stearic or
19
palmitic acids within the molecule and the bonding of the phosphate or headgroup 
was unknown. In addition, the main elements of choline had been identified, but the 
connectivity of the three methyl groups and the hydroxyl group to the nitrogen was 
not known.19 Approximately 10 years later, a structure for lecithin was proposed by 
Maclean showing the appropriate connectivity of acyl chains and a phosphoric acid 
“ radicle" on a glycerol backbone with what was thought to be choline shown 
attached to the phosphoric acid.20 However, the proposed structure of the 
headgroup attached to the phosphoric acid was not as we know it today -  it was 
thought to contain an additional hydroxyl group bound to the nitrogen; it was also 
thought that the phosphocholine headgroup could be located at either the 2nd or 3rd 
carbon of the glycerol backbone.20 The study of pure lecithin was extremely difficult 
prior to the advent of gas chromatography (GC) in the 1940's. Promptly following the 
discovery of lecithin though, distinctions were already being made between lecithin 
and a similar fatty compound containing nitrogen and phosphorus, named kephalin 
or cephalin, usually found together w ith lecithin but w ith decreased solubility in 
alcohol.21 Discoveries of new, but similar compounds rapidly followed. In fact, after 
the discovery of both aminoethanol and serine in cephalin from brain, Folch and 
Schneider hypothesized that the brain may contain two types of cephalins, one 
containing ethanolamine and the other serine.21,22 In response to the discovery of 
these structurally-related compounds containing phosphorus and nitrogen, the term 
"phosphatides" was suggested to describe this group of compounds.19 By the 1940's, 
the term "phospholipid" had been introduced in reference to lipids containing 
phosphorus, including lecithin, cephalin, sphingomyelin and glycerophosphoric 
acid.23 While the discovery of new, related lipids and progress towards appropriate 
nomenclature was fast underway, progress towards the acceptance of the current 
general structure of lecithin was slow. The currently-accepted general structure of 
phosphatidylcholine had been proposed twice, once by the mid 1920's by Griin and 
Limpacher and later in the mid 1930's by Fischgold and Chain.24’ 25 However, this 
"endo-salt form" of lecithin, shown in Figure 1A  (a), was not generally accepted - the 
competing "open formula" structure, shown in Figure 1,4 (b), was supported into the 
early 1950's by theoretical and experimental elemental composition data proposed
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by Baer and Kates, contributing to the wide acceptance of the incorrect "open 
formula" structure that contained an additional oxygen and two additional protons 
for almost half a century.26 27
endo-salt form  <
[R-0-P(0)-0CH2-CH2Nt(CH3)3]
O '
open form ula K
[R-0-P(0)-0CHr CH2N(CH,)3] 
OH OH
Figure 1.4 Phospholipid general structures proposed in the early 20th century.
The "endo-salt form” and the "open formula" for two proposed general structures of 
the phospholipid are shown in (a) and (b) respectively. This figure was created using 
information provided by previous publications.2®28
In 1950, Baer showed that head group migration during hydrolysis may result 
in misleading data that would seem to support the phosphocholine headgroup 
position at either the 2nd or 3rd carbon of the glycerol backbone.28 In doing so, he 
refuted the data existing at the time in support of the existence of 
phosphatidylcholines in nature containing a head group at the sn-2 position (13- 
lecithins).28 By the mid 1960's the currently-accepted general structure of 
phosphatidylcholine had gained wide acceptance in the scientific community.28 30 
This general structure of phosphatidylcholine was further supported in 1979 by the 
publication of the first crystal structure of a lecithin dihydrate, 1,2-dimyristoyl-sn- 
glycero-3-phosphorylcholine.31
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1.2.2 Classical Methods for Structural Analysis of Phospholipids
In the late 19th century, lecithin was thought to be a single molecule. Several 
years later, after a broader array of biological samples were tested, that view had 
expanded to include several possible structures of lecithin due to the discovery of 
several other fatty acid chains within lecithin. However, at this time, the extent of acyl 
chain variation within naturally-occurring phosphatidylcholines was unknown. Early 
in the 20th century, analysis of the fatty acid composition of lecithin in biological 
samples was nonspecific. That is, it was conducted by releasing all fatty acids from 
the parent compounds by either base hydrolysis (saponification) or acid hydrolysis 
and subsequent reaction of these released fatty acids w ith bromine and/or iodine.32- 
34 The degree of unsaturation was determined by calculating the amount, in grams, 
of iodine that would react w ith 100 g of fatty acid (a quantity known as the iodine 
number) as well as calculating the percentage of bromine in bromine derivatives of 
fatty acids; bromine derivatives were then separated by successive steps of 
solubilization and/or precipitation in ether and petroleum to provide more specific 
information about the fatty acid structures.33'35 The naturally-occurring 
polyunsaturated fatty acids corresponding to each bromine derivative could then be 
identified and their abundance estimated. In this way, newly-discovered fatty acids 
like arachidonic acid, 20:4, were identified in the lecithin of biological tissues of cow 
heart, hog brain and sheep brain.33, 35 However, the diversity, let alone the 
stereochemistry, of fatty acids within lecithins remained largely uncharacterized at 
that time.
1.2.3 Lecithinase and Structural Analysis of Phospholipids
Progress began to unveil the structural diversity o f phospholipids around the 
same time as the general structure of lecithin was being elucidated, with a discovery 
that was made while Kyes was working in the Ehrlich lab. Kyes found that a 
combination of iecithin and cobra venom, namely lecithid of venom, had haemolytic 
properties.36,37 This cobra venom could also be inactivated by heating for 30 mins at 
100 °CF  This active component of cobra venom later came to be known as 
lecithinase. Kyes's discovery would soon unlock the door to fatty acyl
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stereochemistry and diversity in phospholipids. He aiso pointed out that the 
solubility of this cobra lecithid in organic solvent differed from that of both lecithin 
and cobra venom, thereby confirming that cobra lecithid was a separate 
compound.37 Shortly thereafter, Manwaring suggested that this lecithid was a partial 
hydrolysis product of lecithin and experiments conducted by Willstatter and 
Ludecke, showed that lecithid of venom differed from lecithin by a single 
unsaturated fatty acid, and thus, lecithid was later known as lysolecithin.32-38 Prior to 
the 1960's, the action o f the active component of snake venom, lecithinase A (later 
known as phospholipase A, then phospholipase A2 (PLA>)) was commonly believed 
to release unsaturated fatty acids from lecithins containing a mixture of saturated 
and unsaturated fatty acids.39 However, both di-unsaturated and di-saturated 
lecithins were found to produce 1 mole each of fatty acid and lysolecithin by 
hydrolysis with lecithinase A, which led to the conclusion that the action of 
lecithinase A must be specific for one particular fatty acid position, either a' or p (i.e., 
s/i-1 or sn-2 respectively), of lecithin.39 Whilst the general structure of lecithin was 
under debate, so was the specificity of snake venom lecithinase in 1960.4Q That would 
soon change when several experiments conducted in the early 1960's by Van 
Deenen and De Hass showed that lecithinase A from snake venom hydrolyzed fatty 
acids at the (3-position (sn-2 position) of synthetic phosphatidylcholines almost 
exclusively.41 Similarly, y-benzyl-p-acyl-a-phosphoglyceride and a (3-acyl- 
lysophosphoglyceride derivative were shown to be hydrolysed while the 
corresponding stereoisomers were not.41 In addition, lecithinase A hydrolyzed L-a- 
phosphoglycerides but not D-a-phosphoglycerides, which also provided evidence in 
support of the stereospecificity of Lecithinase A for one stereoisomer of glycerol over 
its counterpart.41
1.2.4 Phospholipid Fatty Acyl Chain Stereochemistry
1.2.4.1 Development of the General Rule
The discovery of lecithinase in snake venom and the subsequent research 
into its specificity would have a significant impact on the structural analysis of 
phospholipids. By the 1950's, phospholipase A2 was already being used in
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conjunction with GC, liquid chromatography (LC) and thin layer chromatography 
(TLC) to examine the positional distribution of fatty acids in phospholipids of 
biological extracts, such as egg yolk.39 In the 1960's, these same techniques were 
being applied to pork, spinach leaves, many bacterial species, human bile, human 
liver and chylomicrons, mink liver, cod flesh, mackerel, rat liver and more.42"47 By the 
1970's, the list of biological samples investigated in this way expanded to include 
spinach microsomes and chloroplast, cauliflower, mustard seed, cottonseed, sesame 
seed, groundnut, chicken embryo hepatocytes, mycoplasma and others.48 51 Then in 
the 1980's, these types of analyses included taro, castor bean, tobacco, squash, 
tomato, pea, Japanese radish, dandelion, cabbage, oat, wheat and frog 
photoreceptor.52 54 The list of phospholipids analyzed by phospholipase A2 in 
combination with chromatography continued to grow at a rapid rate, however, the 
vast majority o f these studies conducted prior to the 1990's, examined the pools of 1 - 
acyl iysophospholipids alongside the pools of fatty acids released from the sn-2 
position by phospholipase A2. The majority of these studies found that the pools of 
fatty acids released from the sn-2 position were more highly unsaturated than the 
fatty acids still bound to the glycerol backbone at the sn-1 position as 
iysophospholipids. In many of these studies, this led to the assertion that the 
unsaturated fatty acid was usually found at the sn-2 position of phospholipids. 
Decades of these findings led to a tacit acceptance amongst lipid researchers that 
unsaturated fatty acids are found at the sn-2 position of a phospholipid. In fact, 
according to Lehninger's "Principles of Biochemistry'', a popular undergraduate 
textbook, giycerophospholipids, in general, contain a G 5 or Qg saturated fatty acid at 
s/7-1 and a Ci8 or C20 unsaturated fatty acid at sn-2.55 The significance of this trend 
however, is not widely understood. In one recent investigation, two 
phosphatidylcholine sn-positional isomers, 1-stearoyl-2-oleoyl-s/i~glycero-3- 
phosphatidylcholine and 1-oleoyl-2-stearoyl-sn-glycero-3-phosphatidylcholine, were 
used to model the effect on membrane properties of placing the monounsaturated 
fatty acyl chain at the sn-1 and sn-2 positions, respectively.56 Computation predicted 
that altering the position of the unsaturated fatty acyl chain from the sn-2 to the sn-1 
position interfered with membrane cholesterol packing as well as phospholipid
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bilayer membrane order.56 This finding implies an importance to the location of the 
unsaturated acyl chain on the glycerol backbone to the structural integrity of the 
phospholipid bilayer.
1,2.4.2 Exceptions to the General Rule
It is important to recognize that the unsaturated fatty acyl chain is not always 
found at the sn-2 position of a phospholipid. For quite some time, researchers have 
been aware of the exceptions to the rule with discovery of numerous examples of 
glycerophospholipids w ith unsaturated fatty acids at the sn-1 position. By the mid 
1960's, human lymph lecithins were shown to contain saturated fatty acids at the sn-
2 position and unsaturated fatty acids at the sn-1 position.44 Shortly thereafter, in 
1967, Brockerhoff and Ackman stated that while saturated fatty acids always 
predominate at the sn-1 position and polyunsaturated at the sn-2 position of 
glycerophospholipids, the same rule does not hold for monounsaturates.45 This was 
supported later in 1981 when a study of rat fetal lecithin revealed that the trans­
polyunsaturated fatty acid, linoelaidic acid was found primarily at the sn-2 position 
while the frons-monounsaturated fatty acid, elaidic acid was found almost equally at 
sn-1 and sn-2.52 However, this is not the only exception to the rule, as fatty acyl chain 
distribution can vary dramatically across different phospholipid classes. For instance, 
the polyunsaturated fatty acid, 18:3, was found predominantly at the sn-1 position in 
PG from plants such as taro, tomato, cabbage, spinach and oats while it was also 
found predominantly at the sn-2 position of PC from the same plants.53 Several 
studies found that in some bacteria, the fatty acyl chain substitution order can be 
reversed as the saturated fatty acid, palmitic acid, was mainly located in the sn-2 
position and unsaturated fatty acids, hexadecenoic acid and octadecenoic acid, at 
the sn-1 position.46 5157 In 1996, using PLA2 enzymatic assays, soybean phospholipids 
were profiled and labelled such that phospholipids containing two saturated acyl 
chains were denoted "SS", two unsaturated acyl chains "UU", an un saturated fatty 
acid at the sn-1 position with a saturated fatty acid at the sn-2 position "US" and a 
saturated fatty acid at the sn-1 position with an unsaturated fatty acid at the sn-2 
position "SIT.58 The percentage composition of three phospholipid class reported, in
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order of most to least abundant acyl chain composition, was as follows PC: 
UU>SU»US>SS, PE: SU>UU»SS>US, Pi: SU»SS>UU>US.58 According to this study, 
the extent of the general rule claiming the unsaturated fatty acyl chain of a 
phospholipid usually present at the sn-2 position may depend on the phospholipid 
class and/or the type of biological sample analysed. This rule may not even hold true 
in all humans, as in 1997, the phospholipids of red blood cells from patients of sickle 
cell anaemia were found to contain fewer molecular species with polyunsaturated 
fatty acids at the sn-2 position.59 More recently, the incorporation of four conjugated 
linoleic acid isomers into CHO and HepG2 cells was studied. This study found that 
while linoleic acid was preferentially incorporated into the sn-2 position over the sn-1 
position approximately 80% of the time, for CLA isomers containing either two cis 
double bonds or one c/s and one trans double bond, this preference was only 60%.6° 
However, the CL.A isomer, more closely resembling a saturated acyl chain w ith two 
double bonds in the trans configuration, was incorporated into the sn-2 position only 
30% of the tim e.60 This could be indicative of a biological preference for a specific 
fatty acyl chain configuration at the sn-2 position, rather than a preference for a 
higher degree of unsaturation at the sn-2 position. Research presented in Chapter 4 
shows that glycerophosphatidylcholines are probably rarely present as a single sn- 
positional isomer and furthermore, the relative proportion of the two possible 
isomers can vary significantly between tissues and organisms.
1.2.5 Phospholipid Molecular Species using Chromatographic Approaches
A limitation of the phospholipase approach to assigning sn-positions for acyl 
chains in phospholipids is that, in general, they refer to trends across a crude extract 
or fraction and are thus blind to bonding arrangements in individual molecules. The 
first attempts towards a remedy to this problem were creative but somewhat 
laborious, as evidenced by the method developed in 1967 by Kuksis and Marai.54,61 
Briefly, phospholipids extracted from egg yolk were separated into classes using 
silica gel TLC. Phosphatidylcholines were digested with phospholipase C to remove 
the head group, derivatized to form diglyceride acetates, separated by argentation 
TLC into groups according to degree of unsaturation and then analyzed by gas
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chromatography. The molecular weights of the intact diglyceride acetates were 
obtained by GC analysis with tridecanoin as an internal standard. These diglyceride 
acetates were also hydrolyzed with pancreatic lipase, known to have phospholipase 
Ai activity, thus releasing all fatty acyl chains present at the sn-1 position. This pool of 
free fatty acids from the sn-1 [and sn-3] position were analyzed [after derivatization] 
by GC along with the monoglycerides with a fatty acyl chain still attached at the sn-2 
position. The underivatized phosphatidylcholines were also digested with 
phospholipase A2. The resultant pool of free fatty acids released from the sn-2 
position were derivatized [and analyzed by GC]. These datasets were then 
normalized and compared using algebraic manipulation so that phospholipid 
molecular species identities could be assigned based on a best-fit estimate. In the 
early 1980's, the major molecular species of PC and PE in frog photoreceptors was 
reported using this technique.54 Later, the molecular species of human umbilical cord 
and vein endothelial cells were quantified using a similar approach.62 Molecular 
species analysis of phospholipids in biological samples soon became the popular 
analytical method of phospholipids in biological samples in the 1990's, By the early 
21st century, molecular species of phospholipids from human vein and umbilical 
artery cells, cow brain, cow liver, soybean and duck had been analyzed.62 64 The term 
“molecular species" was used as a blanket term that described any phospholipids 
with known fatty acid compositions -  even where the fatty acid substitution 
positions and/or the double bond positions within these fatty acids were not 
known.65' 66 The study of phospholipids in complex biological samples had evolved in 
another way around this same time. Rather than phospholipid profiling alone, these 
phospholipid molecular species were being quantified and compared across 
biological samples with different treatment groups. The phospholipid molecular 
species profiles of multiple groups of related biological samples were analyzed 
including multiple strains of sunflower seeds.67 The effect of modification of the diet 
on phospholipid composition was examined in dog retina in response to diets either 
poor or rich in co-3 fatty acids, in humans in response to an antioxidant-enriched 
meal, as well as in chick tissues in response to dietary supplementation with 
conjugated fatty acids.68™ The effect of disease states (i.e., sickle ceil anaemia) on
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phospholipid molecular species were also studied.59 In 1996, the effect of stimulation 
by thrombin on the alterations in the molecular species of human platelet 
phospholipids was also studied,71 By the early 2000's, the link between biosynthetic 
pathways and the composition of phospholipid molecular species was being 
researched.72 For instance, in saccharomyces cerevisiae, saturated fatty acids were 
found predominantly at the sn-1 position, while for monounsaturated fatty acids, 
palmitoleate was found primarily at the sn-1 position but oleate was found mainly at 
the sn-2 position.73 It was then proposed that, in yeast, PLA2 mediated deacylation of 
phospholipids was followed by reacylation of the lysophospholipid to generate 
specific molecular species of phospholipids.73 It is now known that 1 -acyl sn-glycero- 
3-phosphocholine-O-acyltransferase, or lysolecithin acyltransferase, is responsible for 
transfer of a fatty acid to the sn-2 position of 1-acyl-glycero-3-phosphocholine while 
2-acyl sn-glycero-phosphocholine-O-acyltransferase transfers a fatty acid to the sn-1 
position of 2-acylglycero-3-phosphocholine; saturated fatty acids are preferentially 
transferred to 2-acylglycero-3-phosphocholine and unsaturated fatty acids are 
preferentially transferred to 1 -acylglycero-3-phosphocholine.74
1.2.6 Technological Advancements for Structural Analysis of Phospholipids
By the late 1980's, technological advancements allowed for newer methods, 
electron spin resonance, nuclear magnetic resonance, infrared spectroscopy, X-ray 
scattering, differential scanning calorimetry and mass spectrometry, to be used to 
investigate phospholipid structural features including acyl chain conformation, acyl 
chain motion, acyl chain substitution position and the effect of acyl chain 
unsaturation and substitution position on physical properties of the phospholipid as 
well as higher-order structural properties like acyl chain order in phospholipid 
membranes and membrane dynamics and equilibrium.75 78
1.2.7 Liquid Chromatography and Mass Spectrometry o f Phospholipids
1.2.7.1 LC-MSn for Structural Analysis of Phospholipids
Although mass spectrometry (MS) had been used to study phospholipids prior to 
the 90's, it was during the early- to mid- 1990's that mass spectrometry became, and
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remains today, the method of choice for structural analysis of phospholipids. This is 
evidenced by the shift in phospholipid analytical methods reported in the literature 
over time. This shift, occurred, in large part due to the development of electrospray 
ionization (ESI), which allowed LC to be used in conjunction with mass spectrometry. 
In doing so, ESI allowed the structure of intact phospholipids to be probed in 
interesting ways by mass spectrometry.79' 80 This was a substantial step forward, as 
mass spectrometry offered improved sensitivity and specificity over other LC 
detection methods; for instance UV-absorbance and evaporative light scattering. In 
addition, it provided improved sample throughput, ease of sample preparation and a 
greater level of experimental flexibility, and as a result, a greater level of structural 
information. The natural propensity of these polar lipids to ionize, and exist stably as 
ions, makes these compounds well-suited for analysis by mass spectrometry. 
Multistage mass spectrometry (MSn, where n indicates the number of stages) 
involves multiple stages of mass-to-charge-selection, usually staggered with multiple 
stages of fragmentation of the mass-selected precursor ion, to provide in-depth 
structural information about the initial analyte and its fragment ions. Multistage 
mass spectrometry has been used extensively for structural analysis of 
phospholipids. Though, on its own, mass spectrometry often proves insufficient for 
confident structural assignment when multiple phospholipid isomers or isobars are 
present in the same sample. To remedy this, mass spectrometry is often coupled with 
liquid chromatography (LC) for analysis of phospholipids in biological extracts. In this 
way, phospholipid isomers and isobars can be separated prior to identification using 
mass spectrometry. These LC, MSn and combination LC-MSn methods for the 
separation and/or identification of phospholipids have been comprehensively 
reviewed.79,8193 In the simplest instance, Figure 1.5 illustrates how LC-MS2 can be 
used to obtain structural information, but it is far from comprehensive. Shown in 
Figure 1.5 is the total ion chromatogram for a reversed-phase LC separation of an 
organic extract of sheep brain, the extracted ion chromatogram for m/z 760.5 (a) and 
the corresponding mass spectra for the peak at 64.4 min (b), 65.4 min (c) and 67.3 
min (d).The [M+H]+ and [M+Na]+ precursor m/z values are labelled for PC 16:0_18:1 in 
panel (b) along with fragment ions corresponding to loss of the phosphocholine
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headgroup, or portions thereof. Also labelled in pane! (b) are fragment ions 
corresponding to the loss of acyl chains attached to the glycerol backbone. A 
comparison of the mass spectra shown in panels (b), (c) and (d) for the 
chromatographic peaks eluting at 64.4 min, 65.4 min and 67.3 min respectively, 
shows that there are no major differences in the MS2 mass spectra to facilitate 
differentiation of these isomers. In addition, structural information is limited when 
using LC-MS2 for identification of low abundance phospholipids. This observation is 
supported by the absence of m/z 478 and the low abundance of m/z 504 in the 
magnified region of the mass spectrum shown in panel (d) of Figure 1.5.
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Figure 1.5 LC-MS2 analysis of a sheep brain lipid extract.
The total ion chromatogram and extracted ion chromatogram for m/z 760.5 are 
overlaid for reversed phase chromatography of a sheep brain extract (a). The spectra 
corresponding to the chromatographic peaks at elution times o f 64.4 min, 65.4 min 
and 67.3 min are shown in green (b) red (c) and maroon (d) respectively. Major 
structural ions o f interest are labelled in panel (b). The maximum ion intensity is 
shown in the upper right hand corner of each panel.
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Most pertinent to the research described herein, liquid chromatography can be 
used to separate the major phospholipid classes by head group polarity using either 
normal phase (NP) or hydrophilic interaction chromatography (HILIC), the latter 
being the more recently developed method.82 However, the vast majority of 
chromatographic separations of phospholipids performed today are reversed phase 
or include a reversed phase separation step, as in two-dimensional LC separations of 
phospholipids. Reversed phase chromatography separates phospholipids primarily 
according to acyl chain hydrophobicity characteristics: acyl chain length, degree of 
unsaturation, double bond position, acyl chain conformation and/or acyl chain sn- 
position, for instance. A limited number of phospholipid double bond positional 
isomers and even fewer phospholipid sn-positional isomers have been separated 
using reversed phase chromatography (discussed in further detail in Chapters 2 and 
3). As a result of decades of mass spectrometric analysis of phospholipids, the 
general fragmentation pathway of the main phospholipid classes, as well as many 
more minor classes, is well-understood for different adduct ions, in both positive and 
negative ion modes.79'90 The headgroup of a phospholipid and both fatty acid chains 
can be identified with relative ease using multistage mass spectrometry. However, 
there is not a single MS-based study in existence today that reports phospholipid 
abundances for individual, structurally distinct phospholipids and very few 
distinguish between phospholipid double bond positional isomers and/or 
phospholipid sn-positional isomers. This is due, in part, to the lack of methods 
specific, sensitive and simple enough for the confident structural identification of 
phospholipid isomers, especially in complex biological samples.
1.2.7.2 Mass Spectrometric Methods for Analysis of Double Bond Position in 
Phospholipids
Several mass spectrometric methods exist for the identification of double bond 
position in the acyl chain of a phospholipid (discussed in Chapter 2). While many of 
these methods are specific, many also generate complex spectra containing low 
abundance diagnostic ions and most are not very sensitive. The advantages and 
disadvantages of these pre-existing methods, contrasted with ozone-induced
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dissociation (OzID) used here, are discussed in Chapter 2 and, again in the 
conclusions chapter, in general, these methods are not suitable for the identification 
of phospholipid double bond position in complex biological samples containing 
many phospholipid double bond positional isomers. OzID has been used to identify 
the double bond locations of phospholipid acyl chains by trapping phospholipids in 
the mass spectrometer with ozone. This approach is based on the gas-phase reaction 
of an ionised, unsaturated lipid w ith ozone in the ion-trapping region of a mass 
spectrometer.
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Figure 1.6 LC-OzID analysis of a sheep brain lipid extract
The total ion chromatogram for the OzID scan for m/z 782 (green) and the extracted 
ion chromatograms for OzID ions m/z 517 (red) and 489 (blue) are overlaid for 
reversed phase chromatography of a sheep brain extract (a). The OzID spectra
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corresponding to the chromatographic peaks at elution times of 64,0 min and 64.6 
min are shown in the middle (b) and bottom (c) panels respectively. OzID ions 
indicative of a double bond at the n-7 position are labelled with an asterisk (b). OzID 
ions indicative of a double bond at the n-9 position are labelled with a circle (c). The 
maximum ion intensity is shown in the upper right hand corner of each panel.
Demonstrated in Figure 1.6 for LC-OzID analysis of a sheep brain extract, the 
reaction generates two diagnostic product ions from the ozonolysis of each carbon- 
carbon double bond. These are indicated with asterisks and circles in panels (b) and 
(c), and denote double bonds at positions r>-7 and n-9, respectively. The extracted ion 
chromatograms for these diagnostic ions, m/z 517 and m/z 489, shown in panel (a) 
show that they are unique to each [partially] resolved chromatographic peak of the 
chromatogram. In comparison to Figure 1.5, showing LC-MS2 of sheep brain extract, 
OzID generates abundant, diagnostic OzID ions indicative of double bond position, 
whereas this information is absent in the MS2 spectra. This makes OzID more specific 
and sensitive w ith spectra that are easier to interpret for phospholipid mixtures. The 
presence of isobaric lipids in complex extracts means that when used in combination 
with direct infusion lipid mass spectrometry, OzID of an intact phospholipid ion 
alone does not permit confident assignment of double bond position. As a 
consequence, in this thesis the combination of LC and OzID is described for the first 
time (Chapter 2) and provides for the identification of double bond location of 
phospholipid acyl chains and differentiation of double bond positional isomers in 
complex biological samples.
1.2.7.3 Mass Spectrometric Methods for Analysis of Acyl Chain sn-position in 
Phospholipids
As previously demonstrated in Figure 1.5, conventional collision-induced 
dissociation (CID) mass spectra of ionised phospholipids often yield product ions 
characteristic of headgroup and acyl chain composition {i.e., the number of carbons 
and degree of unsaturation of each chain). However, the sn-position of an acyl chain 
on the glycerol backbone of a phospholipid is more difficult to ascertain. Mass 
spectrometric approaches to determine the substitution position of an acyl chain on 
the glycerol backbone of a phospholipid are discussed in Chapters 3 and 4. Many of
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these methods rely on calculating differences in ion abundance ratios -  which can be 
affected by instrument parameters.99,100 Because each mass spectrometer may have 
different linear dynamic ranges, fragmentation methods, fragmentation energies 
and other parameters that can affect ion fragmentation, transfer and detection, using 
ion ratios or absolute ion intensities (or absolute peak areas) currently requires the 
use of a standard curve for each set of isomers analysed.101 While some of these 
methods are more specific than others, even the best of these approaches becomes 
non-specific when highly unsaturated fatty acyl chains are found in the 
phospholipid, rendering these methods unsuitable for the identification and 
quantification of phospholipids in complex biological extracts. Thus, there is a need 
for improved methodology for the identification of sn-positional isomers in 
biological extracts. A recently-developed method that combines multistage mass 
spectrometry w ith ozonolysis (CID/GzID) is among the most specific and most 
sensitive of these methods.102, 103 The combination of LC with CID/OzID for the 
separation and identification of phospholipid sn-positional isomers has been 
undertaken for the first time in this thesis and is discussed in Chapter 3. Also 
developed for the first time for simple, high-throughput analysis of phospholipid sn- 
positional isomeric composition in complex biological samples was DESI-CID/OzID, 
discussed in Chapter 4.
1.2.7.4 Mass Spectrometric Methods for Imaging of Phospholipid Isomers in Tissue 
One of the drawbacks of using LC in combination with mass spectrometry is that, 
although a large number of phospholipids can be identified in a single 
chromatographic run, the overall analysis time is still relatively slow in comparison to 
direct infusion or desorption electrospray ionization (DESI). In addition, the 
optimization of LC parameters may also be time consuming. In order to meet the 
need for a high-throughput analytical method for relative quantification of 
phospholipid sn-positional isomers in complex biological extracts, DESI was 
combined with CID/OzID as described in Chapter 4 o f this thesis. The instrumental 
setup used for DESI-CID/OzID of extracts is shown in Figure 8.1. However, the analysis 
of a biological sample as a liquid extract is not always ideal. This usually requires
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homogenization and/or extraction of solid biological tissues prior to analysis. In 
doing so, spatial information about variation in relative abundance of phospholipid 
isomers across different regions of the tissue can be lost. As a result, in the last 
decade or so, phospholipid analysis has forayed into the field of mass spectrometry 
imaging (MSI). MSI of phospholipids, including three dimensional MSI, has generated 
much interest and has already been reviewed extensively.104' 13 Briefly, many of these 
methods identified phospholipids using mass spectrometers w ith accurate mass 
capabilities. However, this type of identification allows for the confident 
determination of elemental composition but not for the confident determination of 
molecular structure. Therefore, these methods could not distinguish between many 
types of phospholipid isomers, although phospholipid isomers are known to be 
present in many, if not all, biological tissues. In addition, these high mass accuracy 
imaging methods are often very slow requiring several seconds per scan. Even when 
faster, albeit less accurate, instrumentation was employed for MSI, these methods 
still could not distinguish between phospholipid isomers across different regions of 
an imaged tissue -  including phospholipid double bond positional isomers and srt- 
positional isomers.86 In fact, the vast majority of this phospholipid mass spectral 
imaging research did not employ tandem mass spectrometric techniques and thus, 
many lipid structural features cannot be confidently assigned. In order to work 
towards bridging this gap, DESI was successfully combined with CID/OzID for relative 
quantification of phospholipid sn-positional isomers across different regions of a 
brain tissue section, thus demonstrating the utility of CID/OzID for imaging 
applications. This is described in Chapter 4.
1.2.7.5 Summary of Technologies Developed and Discussed Herein for 
Phospholipid Analysis
A suitable method for the identification of double bond stereochemistry and 
chiral centre stereochemistry w ithin intact phospholipids in complex biological 
samples currently does not exist. However, several methods for the analysis of 
double bond position and sn-position of acyl chains within intact phospholipids do 
exist. Nevertheless, these pre-existing methods are not well-suited for analysis of
37
phospholipids in complex biological samples, especially when phospholipids are 
present at low abundances in these samples and isomers are present. In order to 
work towards improving upon the lack of adequate methods available for complete 
structural elucidation of phospholipids in complex biological samples, LC-OzID has 
been developed to separate phospholipids and identify double bond position in 
complex biological samples (discussed in Chapter 2).114 To the same end, LC- 
CID/OzID has been developed to separate phospholipids and identify phospholipid 
sn-position in complex biological samples (discussed in Chapter 3):,m
Current methods used for structural identification of phospholipids do not match 
phospholipid isomeric variations with regions in tissue, involve time-consuming 
sample preparation procedures and/or lengthy analysis time making these methods 
unsuitable for high-throughput analysis of phospholipid isomers in complex 
biological samples and/or directly from biological tissues. In order to meet the need 
for a simple, fast way to analyze phospholipid structure, at the level of distinguishing 
between phospholipid sn-positional isomers, a simple, high-throughput DESI- 
CID/OzlD method was developed for phospholipid isomeric analysis of complex 
biological extracts. Additionally, DESI-CID/OzlD was used to monitor the changes in 
relative abundances of phospholipid sn-positional isomers across different regions of 
tissue, directly from tissue sections. Thus DESI-CID/OzlD is very promising as an 
imaging technique for monitoring lipid isomeric compositions in different regions of 
tissues.116 DESI-CID/OzlD is discussed in Chapter 4.
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2 COMBINING LIQUID CHROMATOGRAPHY WITH OZONE-INDUCED 
DISSOCIATION FOR THE SEPARATION AND IDENTIFICATION OF 
PHOSPHATIDYLCHOLINE DOUBLE BOND ISOMERS
2.1 Abstract
Revealing the inherent molecular diversity of lipid biology requires advanced 
analytical technologies. Distinguishing phospholipids that differ in the position(s) of 
carbon-carbon double bonds within their acyl chains presents a particular challenge 
because of their similar chromatographic and mass spectral behaviours. Here - for 
the first time - we combine reversed-phase liquid chromatography for separation of 
isomeric phospholipids with on-line mass spectral analysis by ozone-induced 
dissociation (OzID) for unambiguous double bond position assignment. The 
customised tandem linear ion-trap mass spectrometer used in our study is capable of 
acquiring OzID scans on a chromatographic timescale. Resolving the contributions of 
isomeric lipids, that are indistinguishable based on conventional mass spectral 
analysis, is achieved using the combination of liquid chromatography and OzID. 
Application of this method to the analysis of simple {egg yolk) and more complex 
(sheep brain) extracts reveals significant populations of the phosphatidylcholine PC 
16:0 18:1 (n-7) alongside the expected PC 16:0 18:1 (n-9) isomer.
2.2 Introduction
At the cellular level, phospholipids are involved in numerous functions 
including; signalling, modulation of non-lipid biomolecules and maintaining the 
function and integrity of membranes, among other roles.117120 Phospholipids consist 
of a hydrophilic region (containing a phosphate-bound head group such as choline) 
connected to a hydrophobic region (containing a glycerol backbone to which two 
acyl chains are attached). Specific alterations in degree, and location(s) of 
unsaturation within the fatty acyl chains of phospholipids can alter their cellular 
functions.121'12̂ The potential significance of variation in phospholipid double bond 
motifs necessitates the development of analytical tools capable of separating and 
identifying such variants in complex biological extracts.
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Contemporary strategies for the separation and identification of 
phospholipids are focussed on the use of liquid chromatography (LC) generally 
coupled with mass spectrometry (MS). The use of hyphenated LC-MS techniques for 
phospholipid analysis has been reviewed and can be broadly classified by the 
application of either normal- or reversed-phase chromatography.124’ 125 Normal phase 
and hydrophilic interaction LC approaches exploit differences in polar regions of 
lipid structure and have thus been successfully deployed for the temporal 
segregation of phospholipids into different headgroup classes. This approach can aid 
in the quantification of lipids and can be useful in separating lipids of different 
classes that m ight share a common elemental composition {e.g., 
phosphatidylcholines can be separated from isomeric phosphatidylethanolamines). 
Silver ion chromatography combines the affinity of silver ions for carbon-carbon 
double bonds with normal phase LC separation conditions. This approach can bring 
about separations based on differences in the degree, position and stereochemistry 
of unsaturation in lipids but is most generally successful for low-polarity lipids and 
has not been widely deployed in phospholipid analysis.126128 Reversed-phase LC uses 
non-polar stationary phases and can bring about separation of a wide variety of 
lipids, including phospholipids, based on structural differences in their hydrophobic 
acyl chains. Phospholipids possessing different acyl chain lengths and/or different 
numbers of double bonds, e.g., phospholipid compositions of PC 36:1 and PC 36:2 
can be routinely separated using reversed-phase techniques. Examples of separation 
of isomeric phospholipids that contain the same number of double bonds that are 
differentially distributed across the acyl chains, e.g., PC 18:1 _18:1 and PC 18:0_18:2, 
are also relatively common.129 132 In contrast, analytical separations of phospholipid 
double bond positional isomers -  where the acyl chains are themselves isomeric -  by 
reversed-phase LC have proven more challenging. Prepared mixtures of two 
synthetic phosphatidylcholine double bond positional isomers, PC 18:1(n-9)/18:1 (n- 
9) and PC 18:1(n-12)/18:1(n-12), have been successfully separated by reversed-phase 
LC using a Ce column and, more recently, using charged surface hybrid Cis 
columns,133,134 While these analytical demonstrations are important, very few studies 
have differentiated between endogenous double bond positional isomers in
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complex biological extracts. In one such example, Brouwers and co-workers 
extracted lipids from the parasitic worm, S. Mansoni, and subjected these extracts to 
two stages of chromatographic purification.135 Initial lipid class fractionation using 
normal-phase LC was followed by interrogation of the phosphatidylcholine fraction 
on a Cis reversed-phase column with online detection by MS. These analyses 
revealed well-resolved chromatographic peaks corresponding to the phospholipid 
isomers PC 16:0_18:1(n-9) and PC 16:0_18:1 (n-13) that differ only in the position of 
the double bond in the monounsaturated 18:1 acyl chain. The electrospray ionization 
(ESI) mass spectra of such isomeric lipids are identical, while tandem mass spectra 
obtained on most commercial instruments are also similar.136 In order to identify the 
double bond positions within each isomer, Brouwers et a!, collected fractions for 
each isomer and subjected them to further, offline interrogation including the use of 
high-energy collision-induced dissociation.135 This study serves to highlight that 
chromatographic separation alone is insufficient for structure elucidation. Ideally, 
reliable methods for the identification of double bond location in phospholipids that 
can be achieved in real time with chromatographic separation of isomeric 
phospholipids should be developed.
Curtis and co-workers have implemented an ingenious approach to on-line 
lipid isomer analysis by using a gas-permeable membrane to allow ozone to interact 
with unsaturated lipids in the LC eluent prior to MS analysis.137 138 Ozone reacts with 
carbon-carbon double bonds to bring about oxidative cleavage and mass spectral 
analysis of the products enables the assignment of double bond position(s). 
Undertaking this same chemistry inside the mass spectrometer itself may have 
advantages in that the diagnostic products of ozonolysis can be attributed to a 
single, mass-selected population of ionized lipids. We have previously demonstrated 
that mass-selected ionized lipids react w ith ozone in the gas phase in a process 
referred to as ozone-induced dissociation (OzID).133141 The oxidative cleavage of 
carbon-carbon double bonds in the mass spectrometer gives rise to neutral losses 
that are characteristic of double bond position and can be used for structural 
assignment OzID has previously been deployed in combination w ith direct infusion 
electrospray ionization protocols {i.e., "shotgun lipidomics") to characterise lipids in
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complex extracts derived from a range of sources including human ocular lens tissue, 
very-low density lipoprotein and insect pheromones.142144 The direct infusion 
approach -  widely used in lipidomic workflows 90 -  has the advantage of providing 
relatively long acquisition times for OzID but has the disadvantage, in some 
instances, of greater spectral complexity. It would be desirable therefore to be able 
to undertake OzID analysis within both direct infusion and LC-MS workflows with the 
later requiring significant re-optimisation of experimental protocols. Here, for the 
first time, we demonstrate the successful combination of OzID with reversed-phase 
LC for the separation and on-line identification of phospholipid double bond 
isomers. The method was optimized on simple binary mixtures of synthetic 
phospholipid isomers and then challenged by more complex biological extracts.
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2.3 Materials and Methods
2.3.1 Materials
AN solvents used, including water, were Optima LC-MS grade and purchased 
from Thermo Fisher Scientific (Scoresby, VIC, Australia). Formic acid {98% pure); 
sodium citrate (>99% pure); and butylated hydroxytoluene (BHT) were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). Ammonium acetate and sodium acetate 
(both analytical grade) were purchased from Ajax Chemicals (Auburn, NSW, 
Australia). Industrial-grade compressed oxygen was obtained from BOC (Cringila, 
NSW, Australia).
Synthetic phospholipid standards PC 18:1 (n-12)/18:1 (n-12) [1,2-di-(6Z- 
petroselinoyl)-sn-glycero-3-phosphocholine] and PC 18:1(n-9)/18:1(n-9) [1,2-di-(9Z- 
octadecenoyl)-sn-glycero-3-phosphocholine], were acquired from Avanti Polar Lipids 
(Alabaster, Alabama, USA). L-a-Phosphatidylcholine from chicken egg yolk was 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Sheep brain was purchased 
frozen from Kieraville Butchery (Kieraville, NSW, Australia).
2.3.2 Sample Preparation
For direct infusion experiments used to optimize the mass spectrometer the 
lipid standard, PC 16:0/18:1 (n-9), was dissolved to a final concentration of 30 pM in 
water/acetonitrile/2-propanol (50/25/25, v/v) w ith 1 mM sodium acetate. The 
working solution of egg yolk extract was prepared in the same manner with an 
estimated total PC concentration of 1 75 pM.
For chromatographic analyses, standards PC 18:1 (n~9)/18:1 (n-9) and PC 
18:1 (n-12)/18:1 (n-12) were mixed at a 1:1 ratio and diluted to a final concentration of 
40 pM each in water/acetonitrile/2-propanol (50/25/25, v/v). Egg yolk PC extract was 
prepared in the same way as for direct infusion experiments but w ithout the addition 
of sodium acetate. The sheep brain was dissected to obtain one sample each of 
white matter and grey matter from the temporal lobe of the cerebrum. After 
dissection, 20-25 mg of each sample was processed using a bead homogenizer 
(FastPrep-24, MP Biomedical, Seven Hills, NSW, Australia) containing glass beads with
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a 1 mm diameter. Total lipids were then extracted using methanol/chloroform 
according to a modified Folch extraction method.142 145 The lipid extracts from white 
and gray matter were pooled and the combined extract was washed 3 times with 
aqueous ammonium acetate (65 mM), dried under a stream of nitrogen and finally 
reconstituted w ith 750 pL of 2-propanol/acetonitrile (50/50, v/v). All prepared stock 
samples were stored at -80 °C until analysis.
2.3.3 Chromatography
All chromatography was performed using a Waters Acquity UPLC system 
(Waters, Milford MA, USA). For analysis of PC standards, mobile phase A was 
composed of water, formic acid (0.05%, v/v) with sodium citrate (50 pM) and mobile 
phase B was composed of acetonitrile/2-propanol (64/34, v/v), formic acid (0.05%, 
v/v) and sodium citrate (50 pM). For the analysis of egg yolk and sheep brain extracts, 
mobile phase A was composed of water w ith sodium acetate (100 pM) and mobile 
phase B was compsired of acetonitrile/2-propanol (75/25, v/v) w ith sodium acetate 
(100 pM).
Injections of the PC standard mixture (10 pL); PC egg yolk extract (7.5 pL); and 
sheep brain extract (7.5 pL) were loaded onto a reversed-phase Acquity G 8 BEH 
column (1.7 pm, 150 mm x 1 mm J.D., Waters, Milford MA, USA). For the analysis of PC 
standards, the column was heated to 50 °C with a constant flow rate of 100 pL/min. A 
linear gradient was employed ramping mobile phase B from 40.0% to 99.9% over 60 
min and then holding B at 99.9% B for 10 min before the column was re-equilibrated 
at 40% mobile phase B for 15 min. For the analysis of egg yolk PC extract and sheep 
brain extract, the flow rate was set to 125 pL/min. A linear gradient was employed 
ramping mobile phase B from 82.0% to 88.0% over 70 min and then holding mobile 
phase B at 99.9% for 5 min before the column was re-equilibrated for 15 min at 82% 
mobile phase B. All extracts were stored at 5 °C for the duration of the LC analyses 
and discarded after all LC analyses were complete.
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2.3.4 Mass Spectrometry
Mass spectrometry was undertaken on a hybrid triple quadrupoie linear ion- 
trap mass spectrometer (QTRAP 2000, AB SCIEX, Concord, ON, Canada) that has been 
modified for OzID experiments as previously described.140 Minor adjustments were 
made to the online ozone delivery system and a schematic showing the 
configuration used in the present experiments is provided in the Supplementary 
Materials provided in Appendix A (see Figure 6.1). Ozone was generated from 
oxygen at ca. 170 g rrv3 (normal) using an ozone generator (Titan 100 generator, 
Absolute Ozone, Edmonton Canada) at a constant flow of 0.2 L/min and was 
introduced via a variable leak valve (VSE Vacuum Technology, Lustenau, Austria).
All mass spectrometry was conducted in positive ion mode. For direct 
infusion electrospray ionization experiments, synthetic lipid standards dissolved in a 
solvent system comprised of water, acetonitrile and 2-propanol were infused at 8 
pL/min with a declustering potential of 110 V and the source temperature was set to 
70 °C. For on-line LC-MS protocols declustering potentials of 60 and 90 V and source 
temperatures of 200 and 350 °C were used for examining lipid standards and 
extracts, respectively (see LC methods above). Instrument parameters for OzID were 
controlled using a modified method file as previously described.140 Typical conditons 
were: unit mass resolution on the first quadrupoie (see 01 in Supplementary 
Materials provided in Appendix A, Figure 6.1); pre-/post-reaction activation energies 
of 5/30 eV (except as noted); multi-channel acquisition was turned on; fill time for 
ions entering the collision cell (see q2 in Figure 6.1) was 50-200 ms with pre-/post- 
cell lenses (see lenses marked IQ2 and IQ3 in Figure 6.1) set to 25/100 V; and reaction 
time was 2000-4000 ms. For LC-MS analyses of biological samples, the alternating full 
scan (Q3 ion-trap scan) and OzID scans were undertaken thoughout the experiment.
2.3.5 Nomenclature
Lipid nomenclature used here is guided by the recommendations of the Lipid 
MAPS consortium and the recent suggestions of Liebisch etal. for mass spectrometry 
derived data.13' 146 It is instructive for OzID analysis however, to annotate double bond 
position using the traditional nomenclature "n-x" where "n" refers to the number of
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carbon atoms in the chain and subtracting "x" provides the location of the double 
bond relative to the methyl terminus.15 For example, 18:1(9Z) becomes 18:1 (n-9) and 
18:1(11Z) becomes 1.8:1 (h~7). Note that this nomenclature does not define the 
stereochemical configuration of the carbon-carbon double bond {i.e., cis or trans): a 
structural feature not assigned by OzID w ithout reference to standards.
2.4 Results and Discussion
2.4.1 Optimization of OzID Conditions
To optimize the mass spectrometry conditions for OzID, a solution containing 
a commercial egg yolk extract was infused directly into the ESI source operating in 
positive ion mode. Source and solution conditions were optimized for the 
production of, [M+NaT, sodium adduct ions of lipids as these have been shown 
previously to react more rapidly with ozone than protonated analogues.147 Under 
these conditions, abundant ions at m/z 782 corresponding to the [M+Na]+ ion of PC 
34:1 were observed and subsequently mass-selected using the first quadrupole. The 
ions were transmitted to the collision cell where they were trapped in the presence 
of ozone for 2000 ms before being transferred to the linear ion trap for mass analysis. 
Representative OzID spectra obtained from the m/z 782 ion population are shown in 
Figure 2.1. Figure 2.1(a) was obtained using translational energies of 37 eV for ions 
entering the collision cell and the application of a post-reaction energy of 15 eV. 
Peaks corresponding to primary OzID ions are observed at m/z 672 and 688 (marked 
with a filled square, ■) corresonding to neutral losses of 110 and 94 Da, respectively, 
that are diagnostic for a carbon-carbon double bond at an n-9 position (see 
Supplementary Materials provided in Appendix A, Table 6.1 ).136 In addition, a number 
o f abundant ions arising from collision-induced dissociation (CID) are observed at 
m/z 723, 599 and 577 that are characteristic of the [M+Na]+ ions of 
phosphatidylcholines.148 Taken together, the combination of OzID and CID features 
in the spectrum allows the assignment of PC 16:0_18:1 (n-9) as the major lipid at this 
mass-to-charge ratio.
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Figure 2.1 OzID spectra obtained from m/z 782.5 in egg yolk extract
OzID spectra obtained from isolation of m/z 782.5 (predominantly the [M+Na]+ ions 
of PC 34:1) produced upon positive-ion electrospray ionization of a solution 
containing a commercial egg yolk extract, (a) The OzID spectrum obtained using pre- 
and post-reaction energies of 37 eV and 15 eV, respectively, (b) The OzID spectrum 
obtained using pre- and post-reaction energies of 5 eV and 30 eV, respectively. OzID 
product ions indicative of an n-9 (■), n-7 (♦ )  and n-6 (A ) are marked with different 
symbols while ions arising from the recently described CID/OzID processes are also 
marked (U ).102
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Interestingly, many of the CID ions in Figure 2.1(a) also have associated OzID 
peaks. For example, under these conditions the CID product ion at m/z 723 
undergoes OzID to yield product ions at m/z 613 and 629 with the same 
characteristic neutral losses of 110 and 94 Da, respectively, in addition, very 
abundant ions such as the base peak at m/z 379 can be attributed to the recently 
described sequential CID/OzID processes (see also other ions marked by an open 
square (□ ) in Figure 2.1a).102 This complex array of CID and OzID ions can be 
instructive of the structure of the lipids in question, including assigning the position 
of acyl chains on the glycerol backbone.102' m  m  m  141 149 However, in the present 
study where our aim was to combine LC with OzID, we focused on concentrating the 
signal in product ions carrying information on the carbon-carbon double bond 
position. To achieve this the translational energy of ions entering the collision cell 
was minimised to 5 eV (to decrease primary CID processes) while the energy of ions 
exiting the collision cell was raised to 30 eV to convert most OzID ions through to a 
single set of abundant products.140 This approach is illustrated in Figure 2.1 (b) where 
the base peak is m/z 489 which, along with the associated m/z 505 ion, can be 
assigned as OzID ions of the [f\/i+Na]+ precursor ion that have subsequently 
undergone CID with loss of the phosphocholine headgroup (see suggested 
mechanism in Scheme 2.1). The improvement in the abundance in the diagnostic 
ions is apparent by considering the m/z 489 in Figure 2.1(b) is more than 4-fold 
greater than m/z 672 in Figure 2.1 (a). More importantly however, the signal-to-noise 
in these desired mass channels is enhanced with low abundant signals at m/z 517 
and 531 in Figure 2.1 (b) now discernible above the noise. These OzID ions are 
indicative of the presence of a small amount o f an n-1 isomer, most likely PC 
16:0 18:1 {n-1) and a contribution from the [M+2] isotopologue of PC 16:0 18:2(n- 
6,n-9), The instrument conditions used to obtain the OzID spectrum in Figure 2.1 (b) 
were also used in the online LC-OzID experiments described below. While it is 
beyond the scope of the current study, optimization o f experimental conditions for 
other classes of glycerophospholipids (or indeed other lipid classes) could be readily 
undertaken using the same procedure as that documented here for 
phosphatidylcholines.
48
PC 16:0/18:1( n-9)
O zID  
(-110 Da)
C ID  
(- 183 Da)
O
_  +
O  N a
O
/ ' O  +
O  ^ , N ( C H 3 ) 3
O
m/z 782
O  N a
O O
;p ' q
k ^ - N ( C H 3 ) 3
m/z 672
O =
O *  
o ^ O / 0
O  +  
N a
m/z 489
Scheme 2.1 Fragmentation of PC 16:0/18:1 (n-9).
Fragmentation of the [M+Na]+ precusor ion formed from PC 16:0/18:1 (n-9) by 
sequential ozone- and collision-induced dissociation processes to yield abundant 
product ions diagnostic of carbon-carbon double bond position in the target lipid.
2.4.2 LC-MS of synthetic phospholipid isomers
Two synthetic phosphatidylcholines, PC 18:1(n-9)/18:1(n-9) and PC 18:1 (n- 
12)/18:1(n-12), were combined as a 1:1 mixture and subjected to HPLC using a 
reversed-phase Ci8 column (see Methods section). Positive ion ESI of the eluent 
yielded abundant m/z 808 ions {i.e., the [M+Na]+ forms of the two isomeric lipids) that 
were analysed by OzID (Figure 2.2).
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48.5-49.5 min
50.0 - 51.0 min
50 55
Time, min
Figure 2.2 Results of LC-MS analysis of a 1:1 mixture of the synthetic phospholipid 
isomers, PC 18:1 (n-9)/18:1 (n-9) and PC 18:1 (n-12)/18:1 (n-12).
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Shown above is ( a) The region of interest of the chromatogram constructed from 
total abundance of ions detected in OzID scans of mass-selected m/z 808.5. The OzID 
mass spectra obtained by integrating all scans between (b) 48.5-49.5 min and (c)
50.0-51.0 min. (d) Extracted ion chromatograms (XICs) for OzID product ions at m/z 
515 (blue trace) and m/z 473 (red trace). OzID product ions indicative of n-9 (■) and 
n-12 (# ) double bond positions are marked with the symbols noted.
The total ion chromatogram (TIC) constructed from the abundance of all ions 
detected in OzID scans of m/z 808 is shown in Figure 2.2(a) and reveals two distinct 
chromatographic features of near equal abundance. Prior observation of the 
behaviour o f unsaturated phosphatidylcholines on reversed phase columns suggests 
that the peaks eluting at 49.0 and 50.4 min correspond to the isomers PC 18:1 (n- 
9)/18:1(n-9) and PC 18:1 (n-12)/18:1 (n-12), respectively.133"13- Integration of OzID scans 
obtained across each of the chromatographic peaks gave the OzID mass spectra 
shown in Figures 2.2(b) and (c). The base peak in both mass spectra is at m/z 625, 
which corresponds to the neutral loss o f 183 Da (i.e., loss of the choline headgroup) 
from the precursor ion at m/z 808.'48 Distinctive product ion pairs at m/z 515, 531 
(marked as ■ in Figure 2.2b) and m/z 473, 489 (marked as #  in Figure 2.2c) are 
observed in the OzID spectra of the early-eluting and late-eluting chromatographic 
features, respectively. These can be assigned to OzID transitions of 110, 94 Da and 
152, 136 Da from the base peak at m/z 625 that are characteristic of n-9 and n-12 
double bond positions, respectively.14' The bulk of these diagnostic ions are formed 
via sequential OzID then CID activations illustrated in Scheme 2.1 and enable 
unambiguous confirmation of the putative assignments of the chromatographic 
peaks to the n-9 (49.0 min) and n-12 (50.4 min) isomers. The uniqueness of the OzID 
product ions to each isomer is illustrated in Figure 2.2(d) where the extracted ion 
chromatograms (XICs) of m/z 515 (shown as blue trace) and the m/z 473 (shown as a 
red trace) are shown to be fully resolved. It is interesting to note that, despite the fact 
that the isomers were prepared as a 1:1 mixture and show similar peak areas in the 
total ion chromatograms in Figure 2.2(a), the peak area of the m/z 515 selected ion 
chromatogram is approximately double that of the m/z 473 peak. This phenomenon 
arises from the different rates of reaction of the two ionized lipid isomers with ozone 
in the gas phase. The general trend of faster ozonolysis reactions with double bonds
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closer to the methy! terminus of lipid acyi chains has previously been noted.140 This is 
consistent with the current observation where double bonds at the n-9 position react 
faster than those at the n-12 position. Importantly, this result suggests that while ion 
chromatograms generated from OzID transitions can provide an excellent means to 
identify and resolve overlapping double bond isomers, relative quantification using 
these data alone cannot be achieved w ithout calibration of the relative ozonolysis 
reaction efficiencies of the isomers.
2.4.3 LC-MS of complex lipid extracts
Upon optimizing the LC-OzID workflow, this protocol was used to examine 
lipid extracts from chicken egg yolk and sheep brain. The phosphatidylcholine 
composition of such extracts is known to be rich in PC 16:0 18:1, although the 
position(s) of unsaturation have not been fully elucidated.150151
While the chicken egg yolk extract is a relatively simple lipid mixture {i.e., a 
phosphatidylcholine fraction), it is substantially more complex than the standard 
mixtures described above. As a result of the increased complexity the 
chromatographic conditions were adjusted as described above (see Methods). Total 
ion chromatograms showing the elution of all components of the mixture detectable 
under the experimental conditions are provided as Supplementary Materials in 
Appendix A (see Figure 6.2) and also provide evidence for the reproducibility of the 
conditions across two injections. The chromatographic and mass spectral data 
obtained from OzID of m/z 782, corresponding to the [M+Na]+ ion formed from PC 
34:1, is shown in Figure 2.3. In the chromatographic region of interest in Figure 2.3(a) 
the early-eluting components at retention times of 21.3 and 22.4 min are assigned to 
[M+2] isotope contributions from PC 34:2. This assignment was confirmed by 
examining the full-scan mass spectra obtained at these elution times that were 
dominated by ions at m/z 780 (data not shown). The major peak in Figure 2.3(a) is 
centred at 31.3 min and features a discernible shoulder centred at approximately
30.4 min. The OzID spectrum of m/z 782, obtained from averaging the scans across 
the main chromatographic peak, is shown in Figure 2.3(c). This spectrum has a single 
major set of OzID product ions at m/z 489, 505 (marked with ■) corresponding to
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transitions of 110,94 Da from the m/z 599 base peak. The formation of these ions can 
be rationalized according to the sequence of OzID and CID events depicted in 
Scheme 2.1 and confirms the presence of an n-9 double bond in the eluting 
phosphatidylcholines. In contrast, the OzID spectrum obtained from the smaller 
chromatographic feature centred at 30.4 min is dominated by the product ion pair of 
m/z 517,533 (marked with # in Figure 2.3b) corresponding to transitions of 82,66 Da 
from the m/z 599 base peak. These neutral losses have previously been reported to 
arise from oxidative cleavage of an n-7 double bond during OzID (see Supplementary 
Materials in Appendix A, Table 6.1 for a summary of characteristic OzID transitions).136, 
mo, mi yhg n_g OzID product ion at m/z 489 is also observed, albeit at low abundance, 
in the spectrum shown in Figure 2.3(b) and arises from the incomplete 
chromatographic separation of two isomeric lipids that differ in the position of 
unsaturation. Support for this is provided by the overlay of ion chromatograms 
extracted from the diagnostic OzID ions at m/z 489 (n-9 marker ion, red trace) and 
m/z 517 (n-7 marker ion, blue trace) shown in Figure 2.3(d).
53
1.15e7
1.00e7
8.00e6
6.00e6
4.00e6
2.00e6
0.00
PC 16:0  _ 18:1 (n-9)
31.3 TIC OzID (+) 
* m/z 782.5
21
J i
22.4
s L
PC 16:0 _18:1 (n-7)
V
3 0 .4^
L
16 18 20 22 24 26 28 30 32 34 
Time, min
2.7e5
2.5e5
2.0e5
1.5e5
1.0e5
5,0e4
0.0*.
x 2.0 
*
517.3
599.5
503.3
489.3\ 
467.2̂ ®Ẑ \
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Figure 2.3 Results of LC-MS analysis of a purified phosphatidylcholine extract from 
egg yolk for m/z 782.5.
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Shown above is (a) the region of interest of the chromatogram constructed from 
total abundance of ions detected in OzID scans of mass-selected m/z 782.5. The OzID 
mass spectra obtained by integrating all scans between (b) 30.0-30.4 min and (c)
31.0-31.6 min. (d) Extracted ion chromatograms (XICs) for OzID product ions at m/z 
517 (blue trace) and m/z 489 (red trace). OzID product ions indicative of n-7 (♦ )  and 
n-9 (■) double bond positions are marked with the symbols noted.
While LC-MS2 (LC-MS/MS) data has previously been used to assign the sum 
composition PC 34:1 in chicken egg yolk to the fatty acyl composition PC 16:0_18:1, 
those results provided no indication of the presence of double bond positional 
isomers.150 Conversely, the LC-OzID data presented here demonstrate that the PC 
34:1 lipid population in this extract is a mixture of the double bond positional 
isomers PC 16:0 18:1 (n-9) and PC 16:0 18:1 (n-7). While, the chromatographic 
resolution of these isomers is incomplete, we estimate that PC 16:0_18:l(n-9) is some 
4-5 times more abundant that PC 16:0_18:1(n-7) (Figure 2.3a).
The incomplete chromatographic resolution of the PC 16:0_18:1 isomers in 
egg yolk extract stands in contrast to the complete separation of the binary mixture 
of synthetic double bond isomers of PC 18:1 _18:1 (Figure 2.2a). The difference in 
chromatographic performance arises in part because of the greater complexity of the 
biological extract and the greater structural differences between each isomeric pair 
{i.e., two double bonds versus one). This also suggests that separation of double 
bond positional isomers on reversed-phase columns becomes easier as the spacing 
between the sites of unsaturation increases and if double bonds are closer to the 
carboxylate moiety (cf. separation of n-9 and n-12 isomers in Figure 2.2a with 
separation of n-7 and n-9 isomers in Figure 2.3a).135 it is also interesting to note that 
the relative peak areas in the extracted ion chromatograms in Figure 2.3(d) are 
actually representative of the total ion chromatograms shown in Figure 2.3(a). This 
suggests that the ozonolysis rates of the sodiated PC 16:0_18:1 (n-9) and PC 
16:0_18:1 (n-7) isomers are similar. This is in contrast to the pattern observed for the 
PC 18:1 (n-9)/18:1 (n-9) and PC 18:1 (n-12)/18:1 (n-12) (Figure 2.2) where a clear bias 
was observed. This finding suggests that for the PC 16:0_18:1 isomers, extracted 
OzID traces could be used for approximating relative abundance where 
chromatographic resolution alone is insufficient (see below).
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Lipid extracts from sheep brain tissue are substantially more complex mixture 
than phosphatidylcholine fractions from egg yolk. Previous investigations in our 
laboratory have shown phosphatidylcholines of composition PC 34:1 are abundant in 
this tissue and traditional tandem mass spectrometry has been used to assign the 
acyl chain composition to PC 16:0_18:1.1S1 LC-MS analysis of sheep brain extract was 
undertaken using the methods described above and the results are summarised in 
Figure 2,4,
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Figure 2,4 Results of LC-MS analysis of a lipid extract from dissected sheep brain 
tissue.
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Shown above is (a) the region of interest of the chromatogram constructed from 
total abundance of ions detected in OzID scans of mass-selected m/z 782.5. The OzID 
mass spectra obtained by integrating all scans between (b) 30.2-30.8 min and (c)
32.0-32.6 min. (d) Extracted ion chromatograms (XICs) for OzID product ions at m/z 
517 (blue trace) and m/z 489 (red trace). OzID product ions indicative of n-7 (♦ )  and 
n-9 (■) double bond positions are marked with the symbols noted.
The chromatogram extracted from the total abundance of ions detected from 
OzID scans of m/z 782 (Figure 2.4a) shows a low abundance feature centred at a 
retention time of ca. 22.3 min. This retention time is similar to that observed 
previously for the [M+2] isotope contributions from PC 34:2 (cf. Figure 2.3a) and this 
was confirmed by observation of the m/z 780 base-peak in the full scan mass spectra 
obtained at this retention time (data not shown). The chromatogram in Figure 2.4(a) 
is dominated by a large broad peak stretching from 30-33 min and, by analogy to the 
results obtained from egg yolk, this feature is assigned to isomers of PC 16:0_18:1. 
The absence of clear chromatographic resolution however, makes the assignment of 
this peak more challenging. Integration of the OzID scans obtained from the early 
(30.2-30.8 min) and late (32.0 -  32.6 min) eluting portions of the peak yielded the 
OzID mass spectra shown in Figures 2.4(b) and (c), respectively. These spectra are 
clearly distinct and reveal the characteristic OzID ion pairs of m/z 517, 533 
(corresponding to an n-7 double bond) and m/z 489, 505 (diagnostic for an n-9 
double bond, see Table 6.1). These data suggest that the chromatographic feature is 
a composite of the two double bond-positional isomers namely, PC 16:0_18;1(n-7) 
and PC 16:G_18:1(n-9). Extracted ion chromatograms of two of these characteristic 
transitions, m/z 517 (shown as a blue trace, Figure 2.4d) and m/z 498 (shown as a red 
trace, Figure 2.4d), reveal the different chromatographic behaviour of the two 
isomers. The n-7 isomer (30.9 min) elutes earlier than the n-9 isomer (31.8 min), 
which is analogous to the trend observed for the egg yolk extract (Figure 2.3a). 
Overall however, the isomer resolution for the sheep brain extract is lower than that 
achieved for egg yolk. The difference in chromatographic performance can be 
attributed to (i) the greater overall complexity of the sheep brain extract, which has 
significant contributions from all major classes of phospholipid,151 but also (ii) the 
apparently greater contribution of the n-7 isomer in sheep brain. As noted above, for
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the comparison of n-7 and n-9 isomers of PC 16:0_18:1 might be expected to give 
similar detection efficiencies in their respective OzID transitions. As such, the relative 
proportions can be estimated from Figure 2.4(d), suggesting that the ostensibly less 
common n-7 isomer m ight be present at up to 50% of the PC 16:0_18:1(n-9) species.
To assess the efficacy of this method for analyzing more complex lipids, the 
egg yolk extract was also interrogated for isomers of polyunsaturated 
phosphatidylcholines of sum composition PC 36:2. LC-MS results from this analysis 
are summarised in Figure 2.5. The total abundance of all ions observed in the OzID 
scans for m/z 808, corresponding to the [M+Na]+ ion of PC 36:2, are plotted in Figure 
2.5(a) and show three distinct features. The least abundant chromatographic peak, 
centred at 22.5 min, is assigned to the [M+2] isotope contribution of PC 34:3 (a lipid 
previously identified in egg yolk).150 The contribution of these phosphatidylcholines 
was confirmed by the presence of abundant m/z 806 ions in the full mass spectra 
obtained at this retention time (data not shown). The two major chromatographic 
peaks in Figure 2.5(a) are baseline resolved and are centred at 31.4 and 32.8 min, 
OzID spectra obtained from averaging scans across these two peaks are shown in 
Figures 2.5(b) and (c), respectively. The OzID spectrum shown in Figure 2.5(b) is 
nearly identical to that obtained from the synthetic standard, PC 18:1 (n-9)/18:1 (r?-9) 
(see Figure 2.2b). Indeed, even the relative abundance ratio of the diagnostic OzID 
ions at m/z 515 and 531 is identical (ca. 3:1), suggesting that not only are both 
double bonds at the n-9 position but they also carry c/s-stereochemistry 140. The OzID 
spectrum shown in Figure 2.5(c) reveals two sets of OzID ions at m/z 517, 533 
(marked with ■) and m/z 557, 573 (marked with A), representing neutral losses from 
the m/z 625 base peak that are consistent w ith the n-9 and n-6 double bond 
positions in the unsaturated acyl chain of PC 18:0_18:2(n-6,n-9).141 Both the PC 
18:1 _18:1 and PC 18:0_18:2 acyl chain compositions were previously assigned based 
on conventional tandem mass spectral analysis on egg yolk extract.150 The LC-OzID 
results presented here enable the separation of these isomeric forms with 
unambiguous assignment of double bond positions in each case (e.g., see XICs in 
Figure 2.5d).
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Figure 2.5 Results of LC-MS analysis of a purified phosphatidylcholine extract from 
egg yolk for m/z 808.5.
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Shown above is (a) the region of interest of the chromatogram constructed from 
total abundance of ions detected in OzID scans of mass-selected m/z 808.5. The OzID 
mass spectra obtained by intergrating all scans between (b) 31.1-31.7 min and (c) 
32.5-33.1 min. (d) Extracted ion chromatograms for OzID product ions at m/z 515 
(blue trace) and m/z 557 (red trace). OzID product ions indicative of n-6 (A ) and n-9 
(■) double bond positions are marked with the symbols noted.
2.5 Conclusions
The results presented here demonstrate that it is possible to obtain high 
quality OzID mass spectra on a timescale that is compatible w ith conventional LC. 
While OzID scans remain intrinsically slow compared to CID experiments, we have 
shown here that it is possible to obtain up to 20 OzID scans, interleaved with other 
scan functions, during the elution of a chromatographic peak (ca, 1 min). When 
combined with other mass spectral and chromatographic information, this hybrid 
workflow enables the structural elucidation of complex lipids and, importantly, the 
identification of distinct isomeric forms of lipids differing only in the position(s) of 
carbon-carbon double bonds. In complex extracts where chromatographic 
separation of such isomers is poor, OzID enables the LC profiles of each isomer to be 
deconvoluted and, in some instances, the relative proportions of each isomer can be 
approximated. This hyphenated LC-OzID approach has some advantages over 
infusion in simplifying OzID spectra through minimizing isomer overlap and 
removing contributions of [M+2] isotopes. While the methods used here targeted 
specific phosphatidylcholines of interest, examples provided as Supplementary 
Materials, in Appendix A (Figures 6,3 and 6.4) demonstrate that (i) the method can be 
applied to lower abundance, polyunsaturated lipids and (ii) LC-OzID spectra with 
good signal-to-noise can be achieved on even shorter timescales should future 
applications require faster chromatography or the interrogation of more molecular 
species. OzID has previously been shown to work effectively on a wide variety of lipid 
structures in infusion ESI experiments139 so the application of LC-OzID to the 
examination of other classes {e.g., other glycerophospholipids, sphingolipids, 
triacylglycerols) represents a ready extension of the workflows described herein. 
Future workflows for LC-OzID, will take advantage of information dependent 
approaches where OzID scans are triggered based on precursor ion detection in a
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preceding full scan analysis. The ability to conduct the ozonolysis event using data- 
dependent selection criteria {e.g., inclusion lists, exclusion lists, tandem mass spectra 
criteria such as neutral losses, etc.) will ensure that the majority of unsaturated lipids 
are detected and the position(s) of unsaturation within their acyl chains are 
established.
Under the conventional reversed-phase chromatographic conditions used 
here, the closer the double bond of the acyl chain to the carboxylate group, the more 
strongly it was retained on the column {cf. n-9 elutes before n-12, Figure 2.2a). This 
observation is consistent w ith previous reports of separation of double bond 
positional isomers and evidence from new column technologies suggests further 
improvements in isomer separation can be achieved.133 135 Full structure elucidation 
of complex lipids however, also requires separation and/or mass spectral 
differentiation of isomers that differ in (i) the position of acyl chains on the glycerol 
backbone {i.e., sn-positional isomers) and the stereochemistry about the double 
bond(s) {i.e., cis and trans). Some preliminary reports have suggested that separation 
of such isomers is possible in selected circumstances but it is by no means routine.152' 
153 Perhaps the addition of complementary mechanisms of separation, such as ion- 
mobility spectrometry with LC and mass spectrometry may provide a means to 
achieve full structure assignments for lipids in complex biological extracts.149 154 155
Although OzID and other technologies reveal the presence of multiple 
isomeric forms of phospholipids within biological samples, very little is currently 
understood about the biological role and/or evolutionary reason for these 
isomers.136, 141 Future application of LC-OzID to extracts from different biological 
sources will aid in the identification of the presence of isomeric lipids and may assist 
in revealing changes in isomer populations that will provide essential clues as to the 
different role(s) of these isomers in vivo.
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3 SEPARATION AND IDENTIFICATION OF PHOSPHATIDYLCHOLINE 
REGIOISOMERS BY COMBINING LIQUID CHROMATOGRAPHY WITH A FUSION 
OF COLLISION- AND OZONE-INDUCED DISSOCIATION
3.1 Abstract
The differentiation of closely related lipid isomers is increasingly important to 
our evolving understanding of lipid biochemistry but is equally challenging to 
contemporary chromatographic and mass spectral analyses. Recently we have 
described a novel ion activation approach based on combining collision- with ozone- 
induced dissociation (CID/OzID) for identification of the relative acyl chain 
substitution positions in glycerophospholipids. Here we demonstrate, for the first 
time, that CID/OzID can be effectively combined with reversed-phase 
chromatography to enable separation and unambiguous identification of 
regioisomeric pairs of phosphatidylcholines differing only in the arrangement of acyl 
chains on the glycerol backbone,
3.2 Introduction
The composition of the lipidome {i.e., the structure and abundance of 
different lipids within a biological system) can vary significantly between different 
organisms, different organs or even within different regions of the same tissue.17 
While enzymatic regulation, lipid synthesis, recycling pathways and transport all play 
an important role in dictating the molecular structure and abundance of the lipids 
present, factors such as diet, exercise, infection or other insult can also have a 
profound influence.156 In order to unravel these complex biochemical mechanisms 
and to understand the role(s) of lipids in health and disease it is essential to have 
access to sensitive and highly specific methods for the identification and 
quantification of individual lipid molecular species.
Glycerophospholipids are among the most abundant classes of lipids in 
nature and significant attention has been focused on developing analytical methods 
to elucidate the molecular structure of these species and to quantify them within 
complex lipid extracts.80 Contemporary tandem mass spectrometry is an essential 
and powerful tool for such analyses and can provide rapid identification of the class
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of the lipid {e.g., phosphatidylcholine (PC)} and the number of carbons and degree of 
unsaturation in each of the acyl chains {e.g., PC 16:0_20:4 where the presence of a 
saturated 16-carbon chain (16:0) and 20-carbon polyunsaturated chain (20:4) are 
indicated).157 A significant lim itation of commonly deployed mass spectrometric 
assays however, is the inability to differentiate closely related isomeric lipids. For 
example, the collision-induced dissociation mass spectrum of PC 16:0/20:4 (where 
the 20:4 chain is esterified to the sn-2 position on the glycerol backbone) is very 
similar to that obtained from the positional isomer PC 20:4/16:0 (where the 20:4 is at 
the sn-1 position). This challenge is further compounded by the fact that both 
isomers are likely present in many complex extracts.99' 49 Whiie these structures may 
appear quite similar, the biochemistry of the isomers can be profoundly different 
indicating that in order to answer certain biological questions the isomeric pairs 
need to be resolved and separately characterized.
Liquid chromatography (LC) has been extensively used in conjunction with 
mass spectrometry for dramatically reducing the complexity o f lipid extracts prior to 
mass spectral analysis.150,158-164 There are however, only a limited number of examples 
where LC has successfully been combined with mass spectrometry for the separation 
and identification of phospholipid isomers,124 135’ ]S2‘ 153,165 Of these, only one previous 
study has demonstrated successful separation of pairs of phosphatidylcholine sn- 
positional isomers using reversed-phase ultra-high performance liquid 
chromatography,1-  In the same study, tandem mass spectrometry -  specifically MS3 
fragmentation -  was used to assign the molecular structure to each of the separately 
eluting isomers. As noted above however, such product ions are usually not unique 
to a particular isomer and rather the relative abundance of the spectral peaks is used 
to infer the acyl chain substitution positions.99, m  Uncertainty in such structural 
assignments is further compounded by the often-low abundance of the mass 
spectral peaks. Recently our group has developed a novel ion activation method that 
combines collision- and ozone-induced dissociation in sequence (CID/OzID) to yield 
abundant product ions that are diagnostic of sn-position and can thus be deployed 
to identify and differentiate regioisomeric lipids.102 Here we describe, for the first
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time, the combination of LC and CID/OzID into a single workflow to enable the 
separation and identification of phosphatidylcholine sn-positional isomers.
3.3 Materials and Methods
3.3.1 Materials
All solvents used, including water, were Optima LC-MS grade and purchased 
from Thermo Fisher Scientific {Scoresby, VIC, Australia). Analytical-grade butylated 
hydroxytoluene (BHT) was purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Analytical-grade sodium acetate was purchased from Ajax Chemicals (Auburn, NSW, 
Australia). Industrial-grade compressed oxygen was obtained from BOC (Cringila, 
NSW, Australia). The following synthetic phospholipid standards were purchased 
from Avanti Polar Lipids, Inc. (Alabaster, Alabama, USA): PC 18:1/16:0 (1-(9Z- 
octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine); PC 16:0/18:1 (1- 
hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine); PC 16:0/20:4 (1- 
hexadecanoyl-2-(5Z,8Z, 11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine); and 
PC 16:0/22:6 (1 -hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn- 
glycero-3-phosphocholine).
3.3.2 Methods
Stock solutions of all phosphatidylcholine standards were prepared in 
acetonitrile/2-propanol (50/50, v/v) to a final lipid concentration ca. 300-400 pM with 
1% BHT (w/w) and stored at -80 °C until analysis. Using the corresponding stock 
solution, phosphatidylcholine standards, PC 16:0/20:4 and PC 16:0/22:6 were each 
separately diluted using water/acetonitrile/2-propanol (50:25:25, v/v) to a final 
concentration of 40 pM. The phospholipid standards, PC 16:0/18:1 and PC 18:1/16:0 
were mixed at a 1:1 molar rato in water/acetonitrile/2-propanol (50:25:25, v/v) to a 
final total lipid concentration of 80 pM each (i.e., total lipid concentration of 160 pM).
Chromatography was performed using a Surveyor high-performance liquid 
chromatograph system coupled to an LTQ linear ion trap mass spectrometer 
(Thermo Fisher Scientific, San Jose, CA). Injections of 2.5-10 pL of each PC standard 
sample were loaded onto an Acquity C18 BEH column (1.7 pm, 150 mm x 1 mm I.D.,
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Waters, Milford MA, USA }. For all analyses, the column was maintained at 60-65 °C 
and samples held at 5 °C. For analysis of PC standards, PC 16:0/20:4 and PC 16:0/22:6, 
mobile phases were prepared as follows: A: water, sodium acetate (50 pM) and B: 
acetonitrile/2-propanol (75/25, v/v), sodium acetate (50 pM). The gradient elution 
was run at a flow rate of 60 pL/min as follows: 0-10 min: 70% B, 10-90 min: 75% B, 90­
95: 99% B, 95-110 min: 70% B. For the 1:1 mixture of PC 16:0/18:1 (9Z) and PC 
18:1 (9Z)/16:0, the mobile phases were prepared as follows: A: water, sodium acetate 
(70 pM) and B: acetonitrile/2-propanol (66:34, v/v), sodium acetate (70 pM). The 
gradient elution was run at a flow rate of 60 pL/min as follows: 0-60 min: 50-100%B, 
60-63 min: 100% B, 63-75 min: 50% B.
The mass spectrometer has been modified to enable the introduction of 
ozone into the ion trap as previously described.139' 14a 167 All analyses were undertaken 
in positive ion mode and respresentative source conditions included: capillary 
voltage 45 V; ionization spray voltage 4 kV; capillary temperature 200 °C; tube lens 
voltage 180 V. Nitrogen gas served as the sheath gas, auxiliary gas and sweep gas 
and helium as the bath gas with the addition of a small bleed from a continuous flow 
of externally generated ozone (produced at 170 g/Nm3 by a Titan 100 generator, 
Absolute Ozone, Edmonton Canada). These conditions provide a constant level of 
ozone within the ion trap throughout the experiments. The Xcalibur instrument 
control software (Thermo Fisher Scientific, San Jose, CA) was used to trigger an 
alternating full scan MS and a targetted CID/OzID scan with all data acquired in 
centroid mode except for analysis of PC 16:0_ 18:1 isomers, acquired in profile mode. 
The CID/OzID sequence is formally an MS3 experiment where intact [PC+Na]+ ions are 
mass selected (using an isolation width of 5 Th) and subjected to CID (using a 
normalised collision energy of 40). The [PC+Na-183] CID product ion is then re­
isolated (using an isolation width of 3 Th) and trapped for 200-1000 ms, with no 
collision energy, in the presence of ozone. The ion injection time was 100 ms for all 
CID/OzID scans.
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3.4 Results and Discussion
3,4.1 Separation and identification of isomeric phosphatidylcholines
The results of LC-MS analysis of a commercially available, synthetic standard 
provided as 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (annotated 
here as PC 16:0/20:4) are shown in Figure 3.1. The total ion chromatogram for ions at 
m/z 804 (Figure 3.1a), corresponding to the sodium cation of PC 36:4, reveals two 
peaks with maxima at 44.8 and 46.4 min. The presence of two chromatographic 
features with a common m/z suggests the presence of isomeric phospholipids within 
the sample. Previous chromatographic investigations using an extremely similar 
reversed-phase column showed isomer separation could be observed for synthetic 
phosphatidylcholines with PC 36:4 sum composition. In that study, relative peak 
abundances in tandem mass spectra suggested that the major and minor 
chromatographic peaks corresponded to the sn-positional isomers PC 16:0/20:4 and 
PC 20:4/16:0, respectively.153 With these putative peak assignments in mind, 
CID/OzID mass spectra were obtained across the chromatographic peaks at 44.8 and
46.4 min and the results are shown in Figure 3.1(b) and (c), respectively. These 
spectra are obtained by first mass selecting the [M+Na]+ precursor ion and subjecting 
it to CID. Ozone is present in the ion trap throughout the experiment but at 
sufficiently low concentrations that it does not impact on the conventional functions 
of the instrument. For example, the CID spectra obtained under these conditions are 
not significantly affected by the presence of the reagent gas in the helium. In a 
formal MS3 experiment, the product ion at [M+Na-183p was then mass-selected and 
stored in the ion trap for 1000 ms in the presence of ozone. The carbon-carbon 
double bond linking the sn-2 acyl chain to the glycerol backbone in the [M+Na-183]* 
ion is chemically cleaved by the ozone resulting in neutral loss characteristic of the 
acyl chain at this position. The origins of these ions have previously been described 
and the process is briefly summarized in Scheme 3.1.102 The CID/OzID spectrum of the 
first eluting peak (Figure 3.1 b) shows abundant product ions at m/z 427 and 443, 
corresponding to neutral losses of 194 and 178, respectively. Importantly however, 
the observed neutral losses in the CID/OzID spectrum are consistent w ith predictions
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for a 16:0 acyl chain occupying the sn-2 position of the glycerol backbone (Table 3.1) 
and thus support the assignment of the chromatographic peak to the PC 20:4/16:0 
isomer. The CID/OzID spectrum of the late-eluting peak is shown in Figure 3.1 (c) and 
is dominated by the product ion at m/z 379 corresponding to a neutral loss of 242 Da 
with a minor product ion also observed at m/z 395 (-226 Da). Such transitions are 
indicative of the 20:4 acyl chain occupying the sn-2 position and supports the 
assignment of the major chromatographic feature to the expected PC 16:0/20:4. 
Integration of the chromatographic peaks in Figure 3.1 (a) suggests that the synthetic 
phosphatidylcholine, is composed of approximately 88% PC (16:0/20:4) and 12.% of 
the alternate PC (20:4/16:0) isomer; w ith the latter eluting first upon reversed-phase 
chromatography. The presence of low-abundance sn-positional isomers in synthetic 
glycerophospholipids has been noted before."  149, 166 This likely arises from 
transacylation of the intermediate lysophosphatidylcholine during the 
preparation.168 Importantly however, the LC protocol employed here provides 
effective separation of the isomers and the CID/OzID affords rapid identification of 
the isomeric structure of each chromatographic peak. Indeed, visualization of the 
extracted ion chromatograms for the diagnostic product ions at m/z 427 and 379 
(see Figure 3.1 d) provides a selective means to interrogate the chromatographic data 
for the presence of each isomer.
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Figure 3.1 MS analysis of synthetic standard provided as PC 16:0/20:4.
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Shown above is (a) the total ion chromatogram for LC-CID/OzID of m/z 804. (b) The 
CID/OzID spectrum obtained from integrating across the chromatographic peak 
between 44.4-45.4 min. (c) The CID/OzID spectrum obtained from integrating across 
the chromatographic peak between 46.0-47.0 min. (d) The extracted ion 
chromatogram for CID/OzID product ions at m/z 427 (indicative of PC 20:4/16:0) is 
shown in green, while the extracted ion chromatogram for m/z 379 (indicative of PC 
16:0/20:4) is shown in blue.
Table 3.1 List of CID/OzID transitions for common fatty acyl chains.
Displayed below are CID/OzID transitions for common fatty acyl chains when 
substituted at the sn-2 position on the glycerol backbone. Predicted neutral losses 
for fatty acyl chains commonly found in eukaryotes upon OzID of the fragment 
[PC+Na-183]+ resulting from CID of the [PC+Na]+ precursor ion.
Fatty acid
(no. carbon: no. db)
CID/OzID Apparent Neutral loss
(from [PC+Na-183]+trapped w/ 03)
Aldehyde Criegee
16:0 194 178
16:1 192 176
18:0 222 206
18:1 220 204
18:2 218 202
18:3 216 200
20:0 250 234
20:1 248 232
20:2 246 230
20:3 244 228
20:4 242 226
20:5 240 224
22:0 278 262
22:1 276 260
22:2 274 258
22:3 272 256
22:4 270 254
22:5 268 252
22:6 266 250
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Scheme 3.1 CID/OzID dissociation of sn-positional isomers PC 16:0/20:4 and PC 
20:4/16:0.
Aldehyde product ions are shown. Criegee ions are not shown but are 16 Da heavier 
than the aldehydes [cf. Table 3.1) and arise from incorporation of an additional 
oxygen atom upon ozonolysis.
Using a similar LC-MS protocol to that described above, a synthetic standard 
provided as 1 -palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine 
(annotated here as PC 16:0/22:6) was examined. The resulting LC and mass spectral 
data are summarized in Figure 3.2. The total ion chromatogram for ions of m/z 828 is 
illustrated in Figure 3.2(a) and shows two features with maxima at 41.4 and 42.8 min, 
respectively. These features correspond to the [M+Na]f cation of 
phosphatidylcholines with a sum composition of PC 38:6. By analogy with the
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previous example, the early eluting feature would be expected to arise from the less 
abundant PC 22:6/16:0 isomer while the more abundant, late-eluting feature can be 
tentatively assigned to PC 16:0/22:6. CID/OzID mass spectra acquired over each 
chromatographic peak are shown in Figures 3.2(b) and (c) and among other features, 
show product ions consistent with neutral losses of 194 and 266 Da, respectively. 
These signature transitions indicate that the sn-2 acyl chain is 16:0 for the first, 
earlier-eluting peak and 22:6 for the second (cf. Table 3.1) thus confirming the 
assignment based on relative retention time. Integration of the chromatographic 
peaks in Figure 3.2(a) indicates that this phosphatidylcholine sample, is composed of 
approximately 79% PC (16:0/22:6) and 21% of the alternate PC (22:6/16:0) isomer.
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Figure 3.2 LC-MS analysis of synthetic standard provided as PC 16:0/22:6.
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Shown above is (a) the total ion chromatogram for LC-CID/OzID of m/z 828. (b) The 
CID/OzID spectrum obtained from integrating across the chromatographic peak 
between 40.6-41.8 min. (c) The CID/OzID spectrum obtained from integrating across 
the chromatographic peak between 41.2-42.4 min. (d) The extracted ion 
chromatogram for CID/OzID product ions at m/z 451 (indicative of PC 22:6/16:0) is 
shown in green, while the extracted ion chromatogram for m/z 379 (indicative of PC 
16:0/22:6) is shown in blue.
Chromatographic separation of sn-positional isomers has previously been 
shown to become more challenging as the level of unsaturation in the acyl chains is 
reduced and the difference in the relative lengths of the acyl chains is reduced.153 
Therefore, to challenge the LC-CID/OzID protocol developed here a sample was 
prepared consisting of an approximately 1:1 mixture of synthetic 
phosphatidylcholines supplied as 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(annotated here as PC 16:0/18:1) and 1 -oleoyl-2-palmitoyl-sn-glycero-3- 
phosphocholine (annotated here as PC 18:1/16:0). The chromatographic and mass 
spectral results from analysis of this mixture are summarized in Figure 3.3. The total 
ion chromatogram for all signals deriving from m/z 782, corresponding to the 
[M+Na]+ of lipids with the sum composition of PC 34:1, is shown in Figure 3.3(a) and 
provides only a single broad feature w ith no resolution between the two 
components of the mixture. CID/OzID mass spectra averaged across data points from 
the early-eluting and late-eluting portions of the chromatographic peak (indicated 
by the green and blue boxes in Figure 3.3a) are shown in Figures 3.3(b) and (c), 
respectively. These mass spectra share the same product ions, with peaks at m/z 405 
and 421 indicative o f a 16:0 chain at the sn-2 position {i.e., PC 18:1/16:0) and peaks at 
m/z 379 and 395 that are consistent w ith the 18:1 chain occupying the sn-2 position 
{i.e., PC 16:0/18:1). Importantly, the relative abundance of these characteristic 
product ion pairs changes across the chromatographic peak. Spectra obtained 
during the early-eluting part of the peak show m/z 405 and 421 at higher abundance 
than the m/z 379 and 395 ion pair (Figure 3.3b), while in contrast the latter ions are 
more abundant in spectra obtained from the peak tail (Figure 3.3c). The mass 
spectral data thus indicate that two isomer populations are being partially separated 
on the reversed-phase column with PC 18:1/16:0 being more concentrated at shorter
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retention times while PC 16:0/18:1 dominates at longer retention times; consistent 
with relative retention time trends for other phosphatidyicholines as described 
above (cf. Figures 3.1 and 3.2). While the total ion chromatogram shows no clear 
resolution of the isomer populations these can be easily visualized in the extracted 
ion chromatograms for the ions at m/z 405 and 379 shown in Figure 3.3(d). This 
example serves to highlight the unique capabilities of combining reversed phase 
chromatography with the characteristic and abundant mass spectral signatures 
obtained from CID/OzID analysis.
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Figure 3,3 LC-MS analysis o f a 1:1 mixture of two synthetic standards provided as PC 
16:0/18:1 and PC 18:1/16:0.
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Shown above is (a) the total ion chromatogram for LC-CID/OzID of m/z 782. (b) The 
CID/OzID spectrum obtained from integrating across the chromatographic peak 
between 39.9-40.9 min. (c) The CID/OzID spectrum obtained from integrating across 
the chromatographic peak between 41.0-42.0 min. (d) The extracted ion 
chromatogram for CID/OzID product ions at m/z 405 (indicative of PC 18:1/16:0) is 
shown in green, while the extracted ion chromatogram for m/z 379 (indicative of PC 
16:0/22:6) is shown in blue.
3.4.2 Implications for dissociation and oxidation mechanisms
Efforts to understand the unimolecular mechanisms for the dissociation of 
ionized glycerophospholipids in the past, have been hampered by the presence of 
lipid isomers. As illustrated here, the synthetic glycerophospholipids routinely used 
in such studies, typically represent a mixture of both sn-positional isomers. The 
chromatographic separation achieved here however, enables the tandem mass 
spectra of each phosphatidylcholine isomer to be separately acquired and the 
mechanisms of the underlying CID/OzID ion activation processes investigated. 
Comparing the spectra in Figure 3.1 (b) and (c) reveals several interesting differences. 
Outside of the characteristic ions already discussed, the product ion apparent at m/z 
635 is the base peak in Figure 3.1 (b) while it is only a minor contributor to the 
spectrum in Figure 3.1(c). This signal has previously been assigned to the addition of 
oxygen to the mass-selected [M+Na-183]+.102 The fragile nature of this ion leads to 
peak tailing and the assignment of an apparent m/z 635 in centroid mode rather 
than the true m/z 637.169 The greater abundance of this feature correlates with the 
presence of the polyunsaturated chain at the sn-1 position and is consistent with 
other polyunsaturated phosphatidylcholines (cf. m/z 659 in Figure 3.2b). Also of note 
is that the m /z427 and 443 ions that dominate in Figure 3.1 (b) are also present, albeit 
at low abundance, in Figure 3.1(c). The converse does not apply; with no significant 
m/z 379 contributions to the spectrum in Figure 3.1 (b). This is best illustrated in the 
extracted ion chromatograms for the diagnostic ions at m/z 427 and m/z 379 shown 
in green and blue, respectively in Figure 3.1(d). While the m/z 379 trace follows 
exactly the chromatographic profile of the peak at 46.4 min, the m/z 427 trace shows 
features arising from both isomers. A similar - although less pronounced - 
phenomenon is observed for the extracted ion chromatograms shown in Figure
3.2(d) where the m/z 379 signal is exclusive to the peak at 42.9 min, while the m/z 451
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signal is dominant for the peak at 41.3 min but also has some abundance for the 
feature at 42.9 min. This is better illustrated in the chromatograms provided as 
Supplementary Materials in Appendix B (Figure 7.1) where a higher concentration of 
the lipid was loaded onto the column. Taken together, these observations provide 
new insight into the possible mechanisms of ion dissociation for the different sn- 
positional isomers. That is, upon collision-induced dissociation the [(PC 
16:0/20:4)+Na]+ and [(PC 16:0/22:6)+Na]+ cations undergo loss of the headgroup 
exclusively driven by the ester of the sn-2 acyl chain (cf. Scheme 3.1). in contrast, the 
isomeric [(PC 20:4/16:0j+Na] and [(PC 22:6/16:0)+Na]+ cations may exhibit 
competition between nucleophilic attack from the sn-2 and sn-1 acyl chains resulting 
in isomeric 5- and 6-membered dioxalane structures (Scheme 3.2, pathways a and b, 
respectively). Alternatively, a small proportion of energetic [M+Na-183]+ ions may 
isomerise via a transacylation pathway such as that shown in Scheme 3.3. 
Differentiating the mechanistic possibilities in Schemes 2 and 3 is not possible based 
on available data, however these results suggest that the mechanism of dissociation 
can be influenced by the relative position and identity of the acyl chains. These 
experimental observations are consistent w ith recent computational studies of the 
unimolecular dissociation of triacylglycerols where both the relative energetics and 
entropy were found to play a role.170
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Scheme 3.2 Competition between 5- and 6-membered ring formation in the CID of 
the [M+Na]+ ions of PC 20:4/16:0.
This competition could account for the low abundant m/z 379 product ions observed 
in the CID/OzID spectrum of this isomer.
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Scheme 3.3 Possible isomerisation of energetic [M+Na-183]+ ions via a unimolecular 
trans-acylation pathway following CID of [PC 20:4/16:0+Na]+.
This isomerization may account for the low abundant m/z 379 product ions observed 
in the CID/OzID spectrum of this isomer.
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3.5 Conclusions
Consistent with prior work, the separation of sn-positional isomers of 
phosphatidylcholines can be achieved using reversed-phase HPLC, provided that the 
acyl chains are of sufficiently different lengths and degrees of unsaturation. In 
general, the isomer with the unsaturated chain occupying the sn-1 {e.g., PC 
20:4/16:0) position elutes first while the isomer with the unsaturated chain at the sn- 
2 position is more strongly retained on the reversed phase column {e.g., PC 
16:0/20:4). The novel CID/OzID ion activation approach yields tandem mass spectra 
w ith abundant product ions diagnostic of the relative position of the acyl chains on
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the glycerol backbone. The data presented indicate that CID/OzID spectra can be 
readily obtained on the chromatographic timescale and enable simple identification 
of the isomers and thus unequivocal assignment of chromatographic features. In the 
future, these protocols could be programmed into data-dependent workflows with 
consecutive CID and CID/OzID events triggered on abundant lipid ions as they exit 
the column and enter the mass spectrometer.
The product ions obtained in the LC-CID/OzID mass spectra are generally of 
higher abundance and more selective (although not exclusive) than conventional 
CID mass spectral signatures used for this purpose "  This is illustrated by the fact that 
extracted ion chromatograms can be obtained from these diagnostic ions, which can 
assist in resolving isomers that are not completely separated on LC [cf. Figure 3.3d). 
While it is tempting to suggest that these extracted ion chromatograms could 
provide a convenient means to quantify the relative proportions of sn-positional 
isomers, we note that the reaction efficiencies of the different isomeric forms can be 
substantially different; compare, for example, the peak abundances in Figure 3.1(a) 
with the extracted ion chromatograms in Figure 3.1(d). Future work will endeavour 
to better understand and calibrate these response factors to enable relative 
quantification in complex mixtures.
Finally, undertaking CID/OzID analysis of chromatographically resolved sn- 
positional isomers has provided new insight into the differences in dissociation 
behaviour of ionized phospholipids. Our prior work had implied that the CID of 
[PC+Na]+ were largely independent of acyl chain identity.'02 These new data 
however, suggest that the nature of the acyl chains, as well as their position on the 
glycerol backbone, can affect the mechanisms of dissociation and thus potentially 
the structure and branching ratio of product ions.
81
4 A RAPID AMBIENT IONIZATION-MASS SPECTROMETRY APPROACH TO 
MONITORING THE RELATIVE ABUNDANCE OF ISOMERIC 
GLYCEROPHOSPHOLIPIDS
4.1 Abstract
Glycerophospholipids with two, non-equivalent fatty acyl chains can adopt 
one of two isomeric forms depending on the relative position of substitutions on the 
glycerol backbone. These so-called sn-positional isomers can have distinct 
biophysical and biochemical behaviours making it desirable to uniquely assign their 
regiochemistries. Unambiguous assignment of such similar molecular structures in 
complex biological extracts is a significant challenge to current analytical 
technologies. We have recently reported a novel mass spectrometric method that 
combines collision- and ozone-induced dissociation in series (CID/OzID) to yield 
product ions characteristic of acyl chain substitution patterns in 
glycerophospholipids. Here phosphatidylcholines are examined using the CID/OzID 
protocol combined with desorption electrospray ionization (DESI) to facilitate the 
rapid exploration of sample arrays comprised of a wide variety of synthetic and 
biological sources. Comparison of the spectra acquired from different extracts 
reveals that the sn-positional isomers PC 16:0/18:1 and PC 18:1/16:0 (where the 18:1 
chain is present at the sn-2 and sn-1 position of the glycerol backbone, respectively) 
are most often found together in lipids of either natural or synthetic origin. 
Moreover, the proportions of the two isomers vary significantly between extracts 
from different organisms or even between adjacent tissues from the same organism.
4.2 Introduction
Glycerophospholipids are amphiphilic molecules comprised of a hydrophilic 
headgroup anchored by a phosphate ester to one of the terminal positions of the 
glycerol backbone with one or two hydrophobic fatty acids esterified at the 
remaining hydroxyl positions.171 This substitution of the glycerol results in chirality 
about the central carbon with the relative positions of headgroup and acyl chain 
attachment defined by a stereospecific numbering (sn) convention.15 For
82
glycerophospholipids found in eukaryotes, the headgroup is typically esterified at 
the sn-3 position of the glycerol backbone with the fatty acyl chains attached at the 
sn-l and sn-2 positions. While the chirality of glycerophospholipids is thought to be 
largely conserved across different organisms, for lipids w ith non-equivalent fatty acyl 
chains, two regioisomers are possible with alternate substitutions at the sn-1 and sn- 
2 positions. Selective enzymatic digests have been used to examine lipid extracts 
{vide infra) and suggest a general trend for unsaturated fatty acyl chains to be 
preferentially esterified at the sn-2 position.50 There is a growing body of evidence 
however, that suggests both sn-positional isomers are often present and that their 
proportions may vary in lipid pools of different origin. For example. Figure 4,1 shows 
the structures of two sn-positional isomers of a phosphatidylcholine substituted with 
oleic (18:1 (9Z)) and palmitic (16:0) acids; both of which have been observed in 
biological extracts.99,149,166 Given the potential for distinct biological function(s) for 
each sn-positional isomer, there is a need for analytical methods that can rapidly 
distinguish these closely related structures and can monitor their relative 
proportions within complex matrices.
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Figure 4.1 Structures of sn-positional isomers, PC 16:0/18:1 (9Z) and PC 18:1 (9Z)/16:0.
Structures of the phosphatidylcholine sn-positional isomers, PC 16:0/18:1 (9Z) and PC 
18:1 {9Z)/16:0 that differ only in the relative position of the acyl chains on the glycerol 
backbone. The stereospecific numbering (sn) o f carbons of the glycerol backbone is 
indicated.
Existing research suggests different biophysical and biochemical properties of 
glycerophospholipid regioisomers that may confer distinct functions on these 
isomers in nature. For example, differential scanning calorimetry measurements 
found significantly different melting temperatures for hydrated bilayers composed of 
the regioisomers, PC 18:0/16:0 or PC 16:0/18:0, where the longer 18:0 acyl chain is 
substituted at the sn-1 or sn-2 position, respectively,172' M  Indeed, this trend was 
observed between sn-positional isomers of many different acyl chain combinations 
and headgroup classes (including phosphatidylcholines, phosphatidylethanolamines 
and phosphatidylglycerols) and results from different self-packing efficiencies of the 
isomers within the bi layer. Recent molecular dynamics simulations of model 
membrane bilayers incorporating glycerophospholipids and cholesterol reveal
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important interactions between the off-plane methyl groups of the cholesterol and 
carbon-carbon double bonds in the acyl chains of the phospholipids. The availability 
of the double bonds for these preferred interactions is affected by the position of 
substitution of unsaturated acyl chains on the glycerol backbone such that 
membrane disorder was found to be greater for PC 16:0/18:1, where the unsaturated 
acyl chain is located at the sn-2 position compared with membranes comprised of 
the PC 18:1/16:0 isomer.56 The different susceptibilities of isomeric 
glycerophospholipids to peroxidation have also been demonstrated. When present 
in liposomes, 1 -palmitoyl-2-linoleoyl-3-sn-PC {PC 16:0/18:2) was found to be more 
sensitive to oxidation by aqueous radicals while 1 -linoleoyl-2-palmitoyl-3-sn-PC {PC 
18:2/16:0) was more susceptible to attack by lipid-soluble radicals.174
Different biochemical behaviours of glycerophospholipid sn-positional 
isomers have also been shown in vivo. For example, enzymes involved in the 
modification of glycerophospholipids usually have some degree of specificity for 
certain acyl chains and/or the site of acyl chain attachment on the glycerol backbone. 
Human lecithin-cholesterol acyltransferase (LCAT), at first believed to exclusively 
remove the acyl chain at the sn-2 position, has now been shown to have substantial 
activity for removal of specific acyl chains when present at the sn-1 position. 
Interestingly, while human LCAT utilizes 16:0 acyl chains present at the sn-2 position 
of PC, rat LCAT prefers PC with the 16:0 chain at sn-1.175 Many types of secreted 
phospholipase A2 (PLA2) enzymes also have very high specificities for 
glycerophospholipids containing arachidonic acid (20:4) at the sn-2 position.176 Thus, 
if both PC 20:4/16:0 and PC 16:0/20:4 are present in vivo, PLA2 will release arachidonic 
acid almost exclusively from the latter isomer.
Despite growing evidence of the distinct biochemical and biophysical 
behaviours of glycerophospholipid sn-positional isomers, very little is known about 
the contribution of lipid isomers to the lipidomes of cells and tissues. This paucity of 
information arises, in part, from the lack of analytical techniques that are capable of 
(i) the confident assignment of the positions of acyl chain substitution in 
glycerophospholipids; and (ii) the rapid assessment of the relative proportions of sn- 
positional isomers within a complex biological sample. Historically, PLA2 assays of
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lipid extracts (or simplified fractions thereof) have used gas chromatography to 
identify the fatty acids released from the sn-2 positions of all glycerophospholipids 
present.42’ 46,5a 5? Such approaches provide a global picture of how fatty acyl chains 
are distributed throughout the lipidome or w ithin a headgroup-class fraction but do 
not directly identify the substitution pattern(s) at the molecular level.
Modern tandem mass spectrometry approaches enable the rapid 
identification of the acyl chain composition of a mass-selected lipid ion. This is made 
possible due to product ions indicative of acyl chain length and degree of 
unsaturation that are present in the collision-induced dissociation (CID) mass spectra 
of ionized glycerophospholipids. It has been demonstrated that the relative 
abundance of these diagnostic ions is often affected by the relative position of 
substitution on the glycerol backbone and, with care, it can be used to assign the 
structure of the more abundant sn-positional isomer present in an extract. Perhaps 
the most specific example involves tandem mass spectrometry in negative ion mode 
where many glycerophospholipids dissociate to yield lysophospholipid product ions 
from the loss of the acyl chain at the sn-2 position.99,166- m Extracting the relative 
proportions of the sn-positional isomers using such methods relies on comparing the 
abundances of these product ions. Such signals, however, are often of low intensity 
and their relative abundance can also be affected by differences in lipid structure 
{e.g., the identity of lipid headgroup and/or fatty acyl chains); the instrument 
geometry (e.g., ion-trap versus beam-type mass spectrometers); and experimental 
configuration (e.g., the collision energy applied).99 149 Such ambiguity in CID data 
often results in incorrect or over-interpreted reporting of sn-position in 
glycerophospholipids. The identification of this problem has led to new 
nomenclature for the annotation of lipids based on tandem mass spectra that avoids 
the assignment of sn-position unless it has been explicitly determined (see also 
Methods - Lipid Nomenclature).13
We have recently introduced an alternative ion activation method that 
combines collision- w ith ozone-induced dissociation (OzID).102, m  178 In this strategy, 
[M+Na]+ ions formed from glycerophospholipids during electrospray ionization (ESI) 
are mass-selected and subjected to CID to remove the headgroup; the resulting
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product ion is then mass-selected and allowed to react w ith ozone in an ion trapping 
region of the mass spectrometer. In contrast to conventional CID approaches, 
CID/OzID mass spectra show highly abundant product ions that can identify the acyl 
chain at the sn-2 position. Indeed, where both sn-positional isomers are present, the 
relative abundance of the diagnostic CID/OzID ions correlates strongly with the 
relative proportions of the two lipids.149 CID/OzID mass spectra can be rapidly 
acquired and thus the approach can be exploited to survey large numbers of 
biological samples and to explore isomeric variations between lipid extracts. 
Conducting such studies using conventional infusion ESI approaches however, runs 
the risk of contamination by carryover and would thus be rate limited by the time 
required to purge the system between samples. To circumvent these limitations, we 
have exploited desorption electrospray ionization (DESI) to enable rapid screening of 
lipid extract arrays and also examination of lipids directly from tissue sections.105 
Combining DESI w ith the novel CID/OzID ion activation protocol for the first time, 
has yielded new insight into the isomeric composition of glycerophospholipids 
within a diverse range of extracts and also demonstrates how the relative 
populations of sn-positional isomers can vary appreciably, even between adjacent 
tissues.
4.3 Materials and Methods
4.3.1 Materials
All solvents used, including water, were Optima LCMS grade (Thermo Fisher 
Scientific, Scoresby, VIC, Australia). Butylated hydroxytoluene (BHT) was purchased 
from Sigma-Aldrich (St. Louis, MO, USA). Ammonium chloride and sodium acetate 
were analytical grade and purchased from Ajax Chemicals (Auburn, NSW, Australia). 
Industrial-grade compressed oxygen was purchased from BOC (Cringila, NSW, 
Australia). Synthetic glycerophospholipid standards PC 18:1(9Z)/18:1(9Z) (1,2-di-(9Z- 
octadecenoyl)-sn-glycero-3-phosphocholine); PC 16:0/18:1 (9Z) (1-hexadecanoyl-2- 
(9Z-octadecenoyl)-sn-glycero-3-phosphocholine); PC 18:1(9Z)/16:G (1-(9Z- 
octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phosphocholine); PC 18:0/18:1 (9Z) (1- 
octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine); and PC 18:1 (9Z)/
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18:0 (1 -(9Z-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phosphocholine) were 
purchased from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). L-a-Phosphatidylcholine 
from egg yolk was purchased from Sigma-Aldrich (St Louis, MO, USA) and all 
biological tissues used for extractions and tissue sections were purchased from 
Kieraville Butchery (Kieraville, NSW, Australia). Where available, biological replicates 
were obtained and these details are provided as Supplementary Materials in 
Appendix C (see footnote to Table 8.1).
4.3.2 Lipid Nomenclature
Lipid nomenclature used here is guided by the recommendations of the Lipid 
MAPS consortium and the recent suggestions of Liebisch eta!, for mass spectrometry 
derived data.13' 146 Briefly, the number of carbon atoms present in an acyl chain is 
written before the colon and the number of double bonds after the colon, such that 
"18:1" represents an acyl chain containing 18 carbon atoms and 1 double bond. If the 
double bond positions are known, these are noted in brackets after the acyl chain 
double bond number, as counted from the carboxyl carbon of the fatty acid, e.g., 
18:1 (9). If the E/Z configurations of the double bonds are known, they are noted 
within brackets immediately after each corresponding double bond position, e.g., 
18:1 (9Z). For glycerophospholipids, the headgroup class is indicated by the two letter 
abbreviation, e.g., phosphatidylcholine is presented as PC and the acyl chains at the 
{stereospecifically numbered) sn-1 and sn-2 positions are presented before and after 
the forward slash, respectively (e.g., PC 16:0/18:1 indicates 16:0 at the sn-1 position 
and 18:1 at the sn-2 position). Where the acyl chain composition is known but the 
relative positions of the chains on the glycerol backbone are uncertain, or a mixture 
o f isomers may be present, the acyl chains are separated by an underscore, e.g., PC 
16:0_18:1.
4.3.3 Sample Preparation
The synthetic glycerophospholipid standards, PC 16:0/18:1 (9Z), PC 
18:1 (9Z)/16:0, PC 18:1(9Z)/18:1(9Z), PC 18:0/18:1(9Z) and PC 18:1 (9Z)/18:0, were each 
separately dissolved to a final concentration of 200 pM in acetonitrile/2-propanol
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(50/50, v/v). Egg yolk extract was weighed then dissolved in acetonitrile/2-propanol 
(50/50, v/v) to an approximate final concentration of 175 pM total lipid. For biological 
tissues 15-150 mg of tissue was dissected and extracted using a modified Folch 
extraction method.142' m  Briefly, dissected tissues were homogenized using a bead 
homogenizer (glass beads, 1 mm diameter) and extracted using 
methanol/chloroform (33/67 v/v). The organic extract was washed three times with 
water, and once with aqueous ammonium chloride (50 mM) before being dried 
under a stream of nitrogen and redissolved with 750 pL of acetonitrile/2-propanol 
(50/50, v/v). Aliquots (3 pL) of the lipid solutions were deposited onto PTFE sample 
spots on dedicated glass slides (Prosolia, Indianapolis, IN, USA) for DESI analysis. 
Technical replicates of each standard or extract were prepared, with each solution 
applied to a minimum o f four PTFE spots that were rapidly air dried (ca. 5 mins) and 
immediately stored. Sample arrays were stored in an airtight box at -80 °C to avoid 
unwanted oxidation by ambient ozone (see also Supplementary Materials, Appendix 
C, Figure 8.3).179' 180
For direct tissue analysis, one hemisphere of sheep brain cerebrum was flash 
frozen at -80 °C and coronal slices were sectioned to a thickness of 30 pm using a 
Leica cryostat CM1950 (Leica, St Louis, MO, USA) maintained at -17 °C. The sheep 
brain section was then mounted onto a glass slide and stored at -20 °C until analysis.
4.3.4 Mass Spectrometry
Mass spectra were acquired using an linear ion-trap mass spectrometer 
operating Xcalibur 2.0 control software (LTQ Thermo Fisher Scientific, San Jose, CA, 
USA). The instrument has been previously modified to undertake ion-molecule 
reactions.181 Ions were generated using a desorption electrospray ionization source 
fitted with a motorised DESI 2D Source (Prosolia, Indianapolis IN, USA). The LTQ 
heated capilary inlet was replaced with a modified inlet capillary (Prosolia, 
Indianapolis IN, USA). The source was configured with the spray emitter tip  angled at 
55° with respect to the plate, while the height of the emitter tip and the sample stage 
were both optimized with respect to the inlet to maximize signal intensity. The stage 
holding the slide was set at 9 mm in the z-axis while the emitter tip  was set at 11 mm
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in the x-axis, 6 mm in the y-axis and 17 mm in z-axis as determined by the markings 
on the DESI source. A mixture of acetonitrile and isopropoanol (50/50 v/v) containing 
sodium acetate (100 |jM) was used as the spray solvent at a flow rate of 7 pL/mi n for 
analyses o f biological extracts and lipid standards and 2 [jL/min when sampling 
directly from tissue. For long acquisitions, a liquid chromatography pump was used 
to provide a constant flow rate for DESI experiments (Surveyor HPLC system, Thermo 
Fisher Scientific, San Jose, CA). The DESI sample stage was traversed at rates of 50 - 
100 pm/s for analyses of biological extracts and lipid standards and 25 |am/s for 
tissue sections. Mass spectrometer parameters used were as follows: ionspray 
voltage 5.00 kV; capillary temperature 275 °C; the capillary voltage -35.0 V; and tube 
lens 125.0 V. Automatic gain control was turned on (as is the default) but ion counts 
were typically low and thus the instrument always operated with the maximum ion 
injection time of 500 ms. Under these conditions limits of detection for a single 
phosphtaidylcholine on a PTFE spot were estimated at 40 fmol. CID/OzID spectra 
were obtained by operating the mass spectrometer in MS3 mode with ozone present 
in the ion trapping region. CID of the mass-selected [M+Na]+ precursor ion (isolation 
width 5 Th) was performed with a normalized collision energy of 38 (arbitrary units) 
and an activation time of 30 ms. The targeted [M+Na-183]+ product ion was then 
isolated (isolation width 3 Th) and trapped for 200 ms in the presence of ozone 
before mass-selective ejection of all ions from the trap. Experimental parameters for 
ozone-induced dissociation on this platform have been previously described and 
involve the introduction of ozone generated off-line and collected in a plastic 
syringe.139,167 Recent modifications to this procedure enable online generation and 
supply of ozone (see Supplementary Materials, Appendix C, Figure 8.1 for a 
schematic of the instrument configuration), providing a stable concentration of 
ozone over extended periods.140, 147 Both methods have been used to obtain the 
CID/OzID spectra reported herein and these are indicated throughout as "offline" 
and "online", respectively (see also Supplementary Materials, Appendix C, Figure 8.2 
and associated discussion). Spectra used in this study represented an average of co. 
30-70 individual scans.
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4.4 Results and Discussion
4.4.1 Results
The ability of the DESI-CID/OzID method to distinguish sn-positional isomers 
of glycerophospholipids was examined using a pair of synthetic phosphatidylcholine 
standards namely, PC 16:0/18:1(9Z) and PC 18:1 (9Z)/16:0. Each compound was 
prepared in acetonitrile/2-propanol and the solutions were loaded onto arrays of 
PTFE spots on glass sample slides before being dried and subjected to DESI analysis. 
Abundant [M+Na]+ ions were observed from the lipids deposited on each spot and 
these ions were then subjected to CID in the ion-trap mass spectrometer to yield the 
abundant [M+Na-183] product ion resulting from neutral loss of the 
phosphocholine headgroup.88' 148 This product ion was then re-isolated and retained 
in the ion trap in the presence of ozone for 200 ms before the fragment ions were 
mass analyzed giving the mass spectra shown in Figure 4.2.
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Figure 4.2 DESI-CID/OzID mass spectra of synthetic glycerophospholipids.
DESI-CID/OzID mass spectra obtained from [M+Na]+ ions of synthetic 
glycerophospholipids (a) PC 16:0/18:1(92) and (b) PC 18:1(9Z)/16:0. The CID/OzID 
peaks indicative of the presence of the 18:1 chain at the sn-2 position (*) and 16:0 at 
the sn-2 position (■) are marked. The dissociation pathways for the two ionized 
glycerophospholipid sn-positional isomers are indicated above the corresponding 
mass spectra. Putative dissociation pathways are based on the study of Pham eta ! / 02 
and full reaction mechanisms for CID and OzID steps are provided as Supplementary 
Materials in Appendix C (Scheme 8.1). Spectra acquired using offline ozone 
generation (see Methods).
The DESI-CID/OzID mass spectra obtained for PC 16:0/18:1(9Z) and PC
18:1 (9Z)/16:0 are significantly different w ith the former dominated by a base peak of
m/z 379 with a low abundant product ion at m/z 405 (Figure 4.2a), whiie the latter
has a base peak at m/z 405 with the signal at m/z 379 barely visible above the noise
(Figure 4.2b). Previous studies identify the ion at m/z 379, and its companion peak at
m/z 395, as resulting from oxidative cleavage of the 18:1 acyl chain from the sn-2
position o f the glycerol backbone. Conversely, m/z 405 and its companion peak at
m/z 421 are markers for the presence of the 16:0 acyl chain at the sn-2 position. The
CID/OzID reaction pathways giving rise to these diagnostic ions have previously
been proposed102 and are summarized above the relevant spectra in Figure 4.2. Full
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reaction schemes, based on current understanding of the reaction mechanism, are 
provided as Supplementary Materials in Appendix C (see Scheme 8,1). importantly, 
these CID/OzID product ions can thus be used to identify the isomeric composition 
of the lipids present on the surface. The presence of the m/z 405, 421 ion pair in the 
spectrum obtained from PC 16:0/18:1(97) (Figure 4.2a) and conversely the presence 
o f m/z 379 in the spectrum obtained from PC 18:1/16:0(9Z) (Figure 4.2b) suggest that 
neither sample is isomerically pure. This observation is consistent w ith previous mass 
spectrometric and enzymatic analyses of synthetic glycerophospholipids, which find 
some abundance of the alternative regioisomer is nearly always present.99' 149 This is 
likely a result of acyl chain migration during synthesis procedures.168
DESI-CID/OzID mass spectra obtained from both synthetic PC isomers show a 
broad peak centered on m/z 614 (Figure 4.2). This feature has previously been 
suggested to be a fragile epoxide of m/7 615 that dissociates upon mass analysis in 
the ion trap resulting in an unusual broad peak shape and a lower apparent m/z 
ratio.102 Putative structures for these ions, based on prior investigations, are provided 
as Supplementary Materials in Appendix C (see Scheme 8.1) and their appearance as 
broad, tailing peaks of apparently lower mass is consistent w ith the well- 
documented behaviour of fragile ions in ion-trap mass spectrometers.169 182 Another 
interesting observation from the data presented in Figure 4.2 is that the overall 
conversion of the mass-selected m/z 599 into product ions is lower for PC 
16:0/18:1 (9Z) (Figure 4.2a) than for PC 18:1 (9Z)/16:0 (Figure 4.2b), Given that the time 
permitted for reaction of the ions at m/z 599 with ozone (200 ms) is the same for 
each isomer, this observation suggests slightly different rates of reaction for the 
isomeric ions undergoing ozonolysis in each case. As a consequence, for the 
concentration of ozone and the reaction time employed in this study, a slight 
detection bias exists in favour of PC 18:1(92)/! 6:0 over PC 16:0/18:1 (9Z). This small 
bias could be removed by extending reaction times such that m/z 599 was 
completely quenched but this would consequently increase the overall analysis time. 
Comparison to prior measurements of these standards using alternative methods 
(see later) suggested that small bias was acceptable given that the aim of this 
investigation was to develop a method to rapidly probe changes in relative sn-
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positional isomer populations for comparison between extracts rather than to obtain 
absolute concentrations for each lipid.
Once optimized for synthetic glycerophospholipids, DESI-CID/OzlD analysis 
was undertaken for lipid extracts obtained from a range of biological sources. 
Representative mass spectra obtained from m/z 782 produced upon DESI of 
deposited extracts from egg yolk, cow kidney and cow eye lens are shown in Figure 
43. In all cases the spectra are consistent with the [M+Na]+ ions formed from the 
abundant monounsaturated phosphatidylcholine, PC 34:1 and show product ions 
identical to those observed for the PC 16:0_18:1 isomers shown in Figure 4.2. 
Notably, the relative abundance of product ions compared to m/z 599 in the spectra 
in Figure 43  is lower than that shown in Figure 4.2. This reflects the different ozone 
concentration present in the ion trap when each data set was acquired. Significantly 
however, the ozone concentration was constant during the acquisition of all spectra 
in Figure 4.3. As such, the changes in relative abundance of the diagnostic product 
ions pairs at m/z 379, 395 and m/z 405, 421 are evidence of different proportions of 
the sn-positional isomers PC 16:0/18:1 and PC 18:1/16:0 in each of the lipid extracts. 
Even a qualitative comparison of the differences between the spectra shown in 
Figure 4.3 suggests significant variation in isomeric composition between samples. 
For example, in the CID/OzID spectrum from egg yolk (Figure 4.3a) the ion pair at m/z 
379, 395 is dominant with the very little signal for m/z 405, 421 detectable above the 
noise. This suggests that phosphatidylcholines of the form PC 34:1 present in egg 
yolk comprise almost entirely PC 16:0/18:1. Indeed, the very low abundance of 
product ions at m/z 405, 421 suggests that there is very little of the regioisomer PC 
18:1/16:0 present in egg yolk - even less than the isomeric impurity observed for the 
PC 16:0/18:1 synthetic standard {cf. Figure 4.2a). Comparison of the analogous 
spectra obtained from extracts of cow perinephric adipose tissue and kidney medulla 
(Figures 4.3b and c) shows the ion pair at m/z 379, 395 again dominating the product 
ion signals but w ith m/z 405, 421 readily observable. These data suggest that PC 
16:0/18:1 is still the major isomer in these tissues but - unlike egg yolk - significant 
amounts of PC 18:1/16:0 are also present. Intriguingly, variation in the relative 
abundance of the diagnostic product ions is also apparent when comparing spectra
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obtained from different regions of the same tissue (cf. Figures 4.3b and c). Finally, the 
CID/OzID spectrum obtained from a cow ocular lens extract shows product ion pairs 
at m/z 379, 395 and m/z405,421 to be of comparable abundance. This suggests that 
the isomers PC 16:0/18:1 and PC 18:1/16:0 are likely to be present in near equa 
abundance in this tissue.
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Figure 4.3 DESI-CID/OzID mass spectra obtained from m/z 782 corresponding to PC 
34:1 isomers from different biological sources.
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DESI-CID/OzlD mass spectra obtained from the [M+Na]+ ions at m/z 782 
corresponding to PC 34:1 isomers from (a) egg yolk, (b) cow perinephric adipose, (c) 
cow kidney medulla and (d) cow ocular lens. Peaks indicative of the sn-positional 
isomers PC 16:0/18:1 (*) and PC 18:1/16:0 (■) are marked as indicated. Spectra 
acquired using online ozone generation (see Methods).
The DESI interface enabled the rapid acquisition of CID/OzID mass spectra 
from an array of lipid extracts spotted onto sample slides (see Methods). All DESI- 
CID/OzlD mass spectra of m/z 782 ions were dominated by the product ion pairs at 
m/z 379, 395 and m / z  405, 421 indicative of the sn-positional isomers PC 16:0/18:1 
and PC 18:1/16:0, respectively. In some instances, low abundant product ion pairs 
were also observed at m / z  377, 393 and m / z  407, 423 which, by analogy to the 
analysis above, were assigned to the sn-positional isomers PC 16:1/18:0 and PC 
18:0/16:1, respectively. From the spectra acquired at each spot on the array, the 
relative contribution of a single isomer to the PC 34:1 lipid population could be 
estimated by normalizing the abundance (A) of the characteristic ion pair for the 
nominated isomer (e.g., the combined ion abundance [A379+A395] of m / z  379 and 395 
formed from PC 16:0/18:1 as indicated in Equation 1) to the sum of product ion 
signals from all four contributors. Combining these data across replicate 
measurements enabled a more rigorous comparison of changes in isomer profiles 
between lipid extracts o f different biological origins and the results are summarized 
in Figure 4.4. Estimates of the relative contribution of the PC 16:1/18:0 and PC 
18:0/16:1 to the composition PC 34:1 were found to be typically less than 2% (see 
Supplementary Materials in Appendix C, Table 8.1) and are thus not presented in 
Figure 4.4.
_______________ [^379+^395]_______________ ^  100
[(■^3 7 9 + -^ 3 9  5 )  +  ( -^ 4 0 5 + - ^ 4 2 l )  +  (-^3 7 7 + -^ 3 9 4 )  +  (-^ 40  7 + -^ 4 2 3 ) ]
The estimates of relative contribution shown in Figure 4.4 indicate that the 
synthetic samples supplied as PC 16:0/18:1 (9Z) and PC 18:1 (9Z)/16:0 include levels of 
the alternate isomer at c a . 20% and 2%, respectively. These results are consistent
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with recent investigations of synthetic standards using CID/OzID with infusion 
electrospray, ion-mobility separations and enzymatic assays (see Supplementary 
Materials in Appendix C, Table 8.2 for comparison).102,149 In contrast to the synthetic 
standard, PC 34:1 in egg yolk was found to be almost exclusively comprised of a 
single sn-positional isomer. With an estimated abundance of 97% PC 16:0/18:1 this 
extract was found to be the most isomerically pure of any biological sample 
investigated in this study. Cow kidney tissue (medulla) was found to have both 
isomers present with PC 16:0/18:1 and PC 18:1/16:0 estimated to comprise 82% and 
17%, respectively, of the PC 34:1 population. Interestingly, the analogous tissue in 
sheep showed a relative amount of the PC 18:1/16:0 isomer of only 6%, while sheep 
brain tissue had the same isomer present at 15% in white matter and 39% in grey 
matter. Finally, the estimates in Figure 4.4 confirm the preliminary finding that the PC 
18:1/16:0 isomer is likely more abundant than PC 16:0/18:1 in lipid extracts of cow 
eye lens. While these data do not provide absolute quantification of the isomers 
present in these extracts, they provide a unique insight into the substantial variation 
in the relative abundance of these two distinct lipid molecules in samples of different 
biological origin (Figure 4.4).
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Figure 4.4 Estimated abundance of sn-positional isomers of PC 34:1 in biological 
extracts and synthetic standards.
The estimated abundance o f sn-positional isomers PC 18:1/16:0 and PC 16:0/18:1 as a 
percentage of phosphatidylcholines of composition PC 34:1 in different biological 
extracts and commercially available synthetic standards. Isomer contributions are 
estimated from the normalized product ion abundances in DESI-CID/OzID mass 
spectra as described in the text. Product ions assigned to isomers of PC 16:1 _18:0 
were included in all computations but represented < 2% of the composition and are 
thus not shown here. All data points represent an average of at least four technical 
and, where available, biological replicates (see Supplementary Materials in Appendix 
C, Table 8.1). Uncertainties shown represent standard deviation. This graph was 
generated using spectra acquired using offline and online ozone generation 
methods (see Methods).
The data summarized in Figure 4.4 suggest wide variation in isomer 
contributions to the PC 34:1 lipid population. In an effort to establish if this was 
unique to phosphatidylcholines of this composition, the isomeric contributions to PC 
36:1 were also investigated. The same sample arrays were examined by using 
sequential CID of mass-selected [M+Na]4 precursor ion at m/z 810 and subjecting the 
abundant product ion [M+Na~183]+ at m/z 627 to OzID. Thus obtained, the CID/OzID 
spectra yielded a series of product ion pairs that could be assigned to the isomers 
indicated: m/z 379, 395 corresponding to PC 16:0/20:1; m/z 433, 499 corresponding
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to PC 20:1/16:0; m/z 407, 423 corresponding to PC 18:0/18:1 and; m/z 405, 421 
corresponding to PC 18:1 /18:0. Comparing the relative peak areas of these diagnostic 
ions according to an analogous version of Equation 1 enabled an estimate of the 
relative contribution of these isomers to the total PC 36:1 pool. These data are 
provided as Supplementary Materials in Appendix C (Table 8.1) and are summarized 
in Figure 4.5.
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Figure 4.5 Estimated abundance o f sn-positional isomers of PC 34:1 in biological 
extracts and synthetic standards.
The estimated abundance of sn-positional isomers PC 18:0/18:1; PC 18:1/18:0; PC 
20:1/16:0; and PC 16:0/20:1 as a percentage of phosphatidylcholines of composition 
PC 34:1 in different biological extracts and commercially available synthetic 
standards. Isomer contributions are estimated from the normalized product ion 
abundances in DESI-CID/OzID mass spectra as described in the text. All data points 
represent an average of at least four technical and, where available, biological 
replicates (see Supplementary Materials in Appendix C, Table 8.1). Uncertainties 
shown represent standard deviation. This graph was generated using spectra 
acquired using offline and online ozone generation methods (see Methods).
The data presented in Figure 4.5 suggest that commercially available 
synthetic standards PC 18:0/18:1 (9Z) and PC 18:1 (9Z|/18:0 contain detectable 
contributions from the alternate sn-positional isomer at ca, 12% and 6%, respectively.
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This is comparable to the data obtained from synthetic lipid PC 16:0/18:1(92} and PC 
18:1 (9Z)/16:0 (see Figure 4.4). Interestingly however, the PC 36:1 pool of lipids in egg 
yolk shows the presence of both PC 18:0/18:1 at -94%  and PC 18:1/18:0 at -5%  
whereas the PC 34:1 lipids in the same extract are comprised almost exclusively of PC 
16:0/18:1. For the remaining biological extracts the lower abundance of PC 36:1 
compared to PC 34:1 led to lower signal-to-noise in the DESI-CID/OzlD spectra 
obtained from the former. As a result, technical variation was larger in these data; as 
evidenced by the more substantial standard deviations shown in Figure 4.5. 
Notwithstanding this variation, the overall trend is of similar abundance ratios of PC 
18:0/18:1 to PC 18:1/18:0, with the former being substantially more abundant in 
every case. These findings contrast with the widely varying ratios of PC 16:0/18:1 to 
PC 18:1/16:0 reported in Figure 4.4, In a similar way, DESI-CID/OzlD analysis was 
undertaken for lipids of composition PC 34:2 and PC 36:2. The lower abundance of 
these lipids meant that reliable data could not be obtained across the full sample set 
and these results are summarized as Supplementary Materials in Appendix C (see 
Table 8.1).
The observation that adjacent tissue extracts had variation in the relative 
abundance of sn-positional isomers PC 16:0/18:1 and PC 18:1/16:0 {cf. grey and white 
matter extracts in Figure 4.4) suggested that it may be possible to visualise the 
changing isomer populations from direct analysis of the tissue itself. To examine this, 
a thin section of sheep brain tissue was prepared, mounted on a glass slide and 
subjected to DESI ■'CID/OzID, The data acquired from direct analysis of sheep brain 
tissue are summarised in Figure 4.6 and show ion chronograms obtained from the 
single transect of the tissue under the DESI emitter. The extracted ion chronograms 
of the diagnostic m/z 379 and m/z 405 product ions plotted in Figure 4.6 can be 
considered to represent the abundance of PC 16:0/18:1 and PC 18:1/16:0, 
respectively. These data show that the abundance of the m/z 379 ion remains 
relatively constant across the tissue boundaries. In contrast, a substantial drop in the 
relative abundance of the m/z 405 ion is observed in white matter compared to grey 
(see shaded areas in Figure 4.6). This finding suggests that while PC 16:0/18:1 is 
somewhat evenly distributed throughout the brain, PC 18:1/16:0 is differentially
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distributed between grey and white matter. These data represent an important 
proof-of-principle that this approach can be used to visualise changes in lipid isomer 
populations in direct tissue analysis. Similar transects were repeated across the entire 
tissue and the abundance data were reconstructed as mass spectral images. These 
images are provided as Supplementary Materials in Appendix C (Figure 8.4} but the 
low signal-to-noise in these data made resolving the different brain regions 
challenging. Nevertheless, there is some delineation between white and grey matter 
in the image corresponding to the distribution of PC 18:1/16:0 (Figure 8.4b).
1 0 2
Time (min)
Figure 4,6 DESI-CID/OzID analysis of isomers of PC 34:1 desorbed directly from a 
sheep brain tissue section.
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DESI-CID/OzID analysis of isomers of PC 34:1 desorbed directly from a sheep brain 
tissue section. Panels (a) and (b) show a photograph of the sheep brain tissue section 
analyzed with panel (a) digitally coloured to highlight the regions of grey matter 
(blue) and white matter (white), (c) The overlaid extracted ion chronograms acquired 
from a single transect, indicated by the grey arrow in panel (b), for diagnostic ions at 
m/z 379 (dark green) corresponding to PC 16:0/18:1, and m/z 405 (light green) 
corresponding to PC 18:1/16:0. The light blue shading indicates where the transect 
crosses regions of white matter.
4.4.2 Discussion
In this study, we have demonstrated the utlility of DESI-MS in analyzing arrays 
of lipid extracts. No cross-contamination between adjacent samples was noted as 
evidenced by the data obtained from egg yolk showing a near pure sample of the PC 
16:0/18:1 isomer. DESI-MS has proven to be an extremely useful means to rapidly 
survey the phosphatidylcholines present in a diverse range of lipid extracts. 
Combining DESI with ion activation by CID/OzID, for the first time, has enabled the 
acquisition of spectra that uniquely identify the presence of each of the possible sn- 
positional isomers of asymmetric diacylphosphatidylcholines. Such clear 
differentiation of isomeric lipids would not be possible using conventional tandem 
mass spectral approaches. By comparing the relative abundance of diagnostic 
marker ions it has been shown that the relative contribution of each isomer to the 
lipid population can be determined. While only providing an approximation, this 
approach has enabled the comparison of the relative isomer populations in 
biological extracts and has revealed remarkable variation in the proportions of sn- 
positional isomers in nature. Data obtained for the isomeric pair, PC 16:0/18:1 and PC 
18:1/16:0, suggest that while common assumptions that the unsaturated acyl chain is 
found at the sn-2 position are borne out in some biological extracts (e.g., egg yolk), 
such assumptions would lead to the wrong conclusions in others {e.g., the near equal 
proportions of the two possible isomers found in cow ocular lens). Although 
phosphatidylcholines were the only lipid class investigated here, in previous infusion 
ESI studies CID/OzID has been proven effective for examining sn-positional isomers 
of all major glycerophospholipid classes and even some triacylglycerols.102,144 This 
suggests that the methods described here could be deployed in the future to 
examine the similarlities and differences in acyl chain substitution patterns across the
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giycerolipidome. Such data could help in understanding the biosynthetic 
connections between different lipid structures.
Direct analysis of sheep brain tissue by DESI-CID/OzlD has revealed that while 
PC 34:1 is homogeneously distributed throughout, the relative concentration of the 
constituent isomers has local variation (cf. Figure 4.6 and Supplementary Materials, 
Appendix C, Figure 8.4). These data highlight current limitations in imaging mass 
spectrometry for lipid applications where monitoring quasi-molecular ions (enabling 
assignment at the sum composition level, e.g., PC 34:1) or even CID product ions 
(enabling assignment of the acyl chain composition level, e.g., PC 16:0 18:1) may not 
be sufficient to reveal regional differences in lipid abundances. As such, further 
development of targeted ion activation strategies is required, to be used in 
combination with desorption/ionization mass spectrometry to enable more precise 
assignment of lipid molecular structure and distribution. These protocols must yield 
abundant and diagnostic product ions for closely related lipid isomers and must be 
obtained on short timescales and on relatively low abundant ions. The data 
presented here suggest that, with further optimization, CID/OzID may serve as one 
such method for future applications.
4.5 Conclusions
The results of the current study serve to reinforce the importance of careful 
annotation of lipid mass spectral data to ensure lipid structures are not incorrectly 
assigned to a single sn-positional isomer based only on CID data. Based on our 
findings it seems reasonable to project that in most living systems both isomers are 
present albeit in different proportions. The underlying reasons for these subtle, 
molecular-level differences between lipidomes remains to be determined. It is clear 
however, that understanding the biological roles of different lipid isomers requires 
analytical tools such as those described here.
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5 CONCLUSIONS AND FUTURE WORK
5.1 New Findings
5.1.1 Methodology
5.1.1.1 LC-OzID advantages
LC-OzID has been used successfully for online separation and identification of
phospholipid double bond positional isomers in mixtures of phospholipid standards,
simple biological extracts and complex biological extracts (see Chapter 2). LC-OzID
methods optimized herein show that it is possible to chromatographically resolve
some phospholipid double bond positional isomers with online OzID providing the
location of the double bond present in the acyl chain of each eluting phospholipid.
The reversed phase LC method used here for LC-OzID analyses can accomplish more
challenging separations than those accomplished by previously-published LC
methods. This is evidenced by the separation of PC 16:0_18:1 (n-7) from PC 16:Q_18:1
(n-9) using LC OzID whereas previous methods, discussed in Chapter 2, were only
able to separate PC 16:0 18:1 (n-9) from PC 16:0 18:1 (n-12) or PC 16:0 18:1 (n-13),
which are more easily separated. By modifying the parameters of the OzID scan
slightly, it is possible to simultaneously identify the double bond location and the
location of each acyl chain on the glycerol backbone (sn-position) or identify solely
double bond position at a 2-3 fold increase in sensitivity in addition to a proportional
decrease in mass spectral complexity. The chromatographic protocol proposed in
this thesis for use with OzID has been used to successfully separate phospholipid
double bond positional isomers in complex biological samples. The LC-OzID method
discussed here is thus a useful analytical tool for partial separation of isomers with
unambiguous identification of double bond position(s); even within in complex
biological samples. In addition, by using the LC-OzID approach described in Chapter
2, the LC-MS TIC can be used for quantification while the LC-OzID TIC is used for
identification of phospholipid double bond positional isomers. In cases where the
chromatographic resolution is inadequate, extracted ion chromatograms for OzID
ions can reveal the presence of isomers and provide a guide to changing populations
of isomers between samples even where these isomers cannot be clearly
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distinguished from visually inspecting the TIC for the OzID scans or the MS scans 
(Figure 2.4).
LC-OzID has several advantages over pre-existing methods for the 
identification of double bond position. High energy CID and multistage mass 
spectrometry of alkali metal-adducted lipids are the most common approaches to 
isomer discrimination presented in the literature.136 In comparison, LC-OzID offers 
improved signal-to-noise of diagnostic ions and greatly reduced mass spectral 
complexity. Another recently published approach also uses liquid chromatography 
in conjunction with ozonolysis for the identification of double bond position in 
phospholipids.138 These authors use hydrophilic interaction liquid chromatography 
(HILIC) in combination with reversed-phase chromatography for 2-D 
chromatographic analysis prior to ozonolysis. In addition, the ozonolysis is 
conducted after lipids elute from the column and before they enter the mass 
spectrometer so that all phospholipids eluted travel through the semi-permeable 
Teflon tubing to react with ozone. LC-OzID offers several advantages over this 
approach, in that ions of a selected m/z can be isolated and trapped with ozone for a 
desired period of time (with trapping times as short as 500 ms), with the ability to 
continuously switch between full MS scans and LC-OzID. This ability to obtain both 
full scan and OzID scans in the same chromatographic run aids in the identification of 
phospholipids from ozonolysis product ions and can improve the apparent 
chromatographic resolution, and thus quantification and identification, by 
implementing data dependent acquisition protocols. In addition, because 
phospholipid isomers are reacted with ozone inside the mass spectrometer, and not 
within the post column tubing, the post column tubing length and internal diameter, 
and thus the extra-column volume, can be minimized for maximal chromatographic 
resolution. LC-OzID also makes use of sodiated phospholipid ions that react 
approximately 5x faster than their protonated counterparts in the gas phase, offering 
improved apparent chromatographic resolution and/or sensitivity.139 However, it is 
also possible that this may not translate to ozonolysis in solution. Finally, the 
chromatographic method used here for LC-OzID was able to resolve phospholipid 
double bond positional isomers {i.e., PC 16:0_18:1 (n-9) and PC 16:0_18:1 (n-7)) in
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multiple types of complex biological extracts whereas evidence was not presented to 
support the capability of the aforementioned method combining 2D-LC with 
ozonolysis to separate and identify these same types of phospholipid double bond 
positional isomers in complex biological samples,
5.1.1.2 LC-OzID limitations
Like any method, LC-OzID also has limitations. While the chromatographic 
method used could separate phospholipid isomers with double bonds differing by 
only two positions {e.g., n-9 and n-7), not all phospholipid double bond positional 
isomeric pairs could be baseline separated using this LC-OzID method .153 However, 
this decreased chromatographic resolution did not affect the ability of LC-OzID to 
identify each phospholipid double bond position. Also, as mentioned in Chapters 2 
and 3, because the reactivity of double bonds within a phospholipid is dependent on 
the structural environment of the double bond (including double bond position, 
stereochemical configuration and any adjacent double bonds) extracted ion 
chromatograms for ozonolysis products generated from LC-OzID chromatograms 
cannot currently be used for absolute quantification of phospholipid isomeric pairs 
w ithout the use of an identical set of phospholipid standards.140 LC-OzID can 
however, still be used for relative quantification of phospholipid double bond 
positional isomers across multiple extracts. The instrumental setup for LC-OzID, 
described in Chapter 2, can either be used to identify double bond location alone or 
it can be used to simultaneously obtain information about both the acyl chain sn- 
position and double bond location but it cannot currently be used to determine acyl 
chain sn-position alone. Another consideration is instrument modification. Although 
OzID provides several advantages over other ozone-free methods, it involves 
additional laboratory equipment including an ozone generator, modification of a 
mass spectrometer and associated health and safety considerations.167
5.1.1.3 LC-ClD/OzID Advantages
Using the experimental setup described in Chapter 3, LC-CID/OzID has been 
used to separate and identify phospholipid sn-positional isomers. In this way, it is 
possible to generate easily-interpretable mass spectra for high-sensitivity
108
identification of phospholipid acyl chain sn-position. The chromatographic method 
described for LC-CID/OzID does not require the purchase or use of newer, more 
expensive chromatographs and can still successfully separate some phospholipid sn- 
positional isomers with near-baseline resolution. The separation of phospholipid sn- 
positional isomers has not previously been demonstrated using conventional HPLC 
{although UPLC separations have been reported). This HPLC method is powerful 
enough to elucidate the contributions of phospholipid sn-positional isomers that 
could not be visualized using traditional LC-MS methods {e.g., the isomeric pair PC 
16:0/18:1 (9Z) and PC 18:1 {9Z)/16:0). Also, when LC is combined with alternating 
CID/OzID and MS scans in a single chromatographic run, the LC-MS scans can be 
used to calculate peak area for quantification of phospholipid sn-positional isomers 
while the LC-CID/OzID scans can be correlated w ith the LC-MS scans and used for 
identification of phospholipid double bond positional isomers. For the identification 
of acyl chain location within a phospholipid, CID/OzID is more specific than other 
pre-existing methods. This is because other approaches typically rely on ion 
abundance ratios to determine relative amounts of isomeric phospholipids. For 
example, a method that uses chemical ionization in conjunction with HPLC can be 
used to determine the acyl chains belonging to a phospholipid .161 As an example of a 
more recently-developed method, phospholipids can be analyzed in positive ion 
mode and the neutral loss of a fatty acid resulting from CID of either protonated or 
lithiated adduct ions are used to assign acyl chain location.79 Reliable quantification 
using these methods is difficult as diagnostic ion populations can be affected by 
instrument parameters such as collision energy and instrument geometry. Given 
such limitations these methods, at most, confirm the presence of the most abundant 
phospholipid isomer. Quantitative data can only be acquired with careful use of a 
standard curve obtained from phospholipid standards. "  In contrast however, a 
comparison of CID/OzID to conventional PLA2 enzymatic digests showed greater 
agreement than CID alone.149 Another advantage over most existing approaches is 
the improved signal-to-noise of CID/OzID diagnostic product ions over those of the 
aforementioned methods. This makes use of competing methods with LC 
challenging, especially for the identification of low-abundance phospholipids and/or
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samples containing mixtures of phospholipids that cannot be separated. The most 
recent method used to separate and identify phospholipid sn-positional isomers 
using combination LC and MSn (neutral loss of fatty acid as ketene in negative ion 
mode), successfully separated several phosphatidylcholine sn-positional isomers.153 
Next to LC-CID/OzID, this method is debatably the most useful method for the 
separation and identification of highly unsaturated phospholipid sn-positional 
isomers. This method was not however, able to separate pairs of phospholipid sn- 
positional isomers containing two sites of unsaturation, whereas LC-CID/OzID was 
able to partially resolve a phospholipid sn-positional isomeric pair containing only a 
single site of unsaturation. Recently, DESI-CID/OzID was developed to provide a fast 
alternative to LC separation, while still identifying phospholipid sn-positional isomers 
in complex biological samples -  this is discussed in Chapter 4 and summarized later 
in this chapter.
5.1.1.4 LC-CID/OzID Limitations
There are several limitations to the use of LC-CID/OzID for the analysis of 
phospholipid sn-positional isomers. Although this LC method is a powerful 
chromatographic method developed for the separation of intact phospholipid sn- 
positional isomers, some phospholipid sn-positional isomers could not be separated 
with baseline resolution, such as PC 16:0/18:1 (9Z) and PC 18:1 (9Z)/16:0. This 
decreased chromatographic resolution did not affect the ability of CID/OzID to 
identify phospholipid acyl chain sn-position. As discussed in Chapter 4, it is also 
important to remember that the CID/OzID reaction rate can vary slightly depending 
on the acyl chain composition. Therefore, not only does the sensitivity of this method 
decrease for some highly-unsaturated phospholipid isomers, LC-CID/OzID alone can 
only currently be used for relative quantification of phospholipid sn-positional 
isomers. Extracted ion chromatograms generated for CID/OzID product ions are not 
currently recommended for quantification outside of elucidating changing 
populations within an isomeric pair across multiple samples.
While the specificity of LC-CID/OzID can decrease with certain phospholipids, 
the same can be said of the aforementioned competing method combining LC with
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neutral loss o f phospholipid fatty acids as ketenes.153 In the latter case, this non­
specificity seems to preferentially affect highly unsaturated pairs of phospholipid sn- 
positional isomers, which also appears to be the case with LC-CID/OzID, however, to 
a lesser extent.
5.1.1.5 DESI-CID/OzID Advantages
The combination of DESI with CID/OzID can be used for high-throughput 
comparison of relative quantities of phospholipid sn-positional isomeric pairs in 
mixtures of phospholipid standards, simple biological extracts and complex 
biological extracts. Information about the spatial distribution of phospholipid sn- 
positional isomers can be obtained using DESI-CID/OzID {see Chapter 4). The 
abundant diagnostic ions generated by CID/OzID facilitate relatively short scan times 
enabling acquisition of data from DESl-generated ions. This strategy facilitates high- 
throughput analysis of phospholipid isomers from sample spots and directly from 
tissue sections. Indeed, DESI-CID/OzID has successfully been used to image relative 
quantities of phospholipid sn-positional isomers in different regions of a sheep brain 
tissue section at a spatial resolution of co. 300 [am (see Figure 8.4).
5.1.1.6 DESI-CID/OzID Limitations
One limitation of DESI-CID/OzID is that the ozone concentration, gas flow rate 
and ion trapping time must be consistent in order to compare DESI-CID/OzID results 
across multiple days. A control sample must be analyzed across multiple days along 
with the samples of interest in order to allow for accurate normalization of the 
variation in phospholipid sn-positional isomer abundance due to variations in 
ozonolysis conditions. This is not a large concern with the online ozone generation 
setup, but should be considered when using the offline ozone generation setup (see 
Figure 8.1). Another limitation of this method is that even with a commercially 
available DESI source, small changes in DESI source parameters may correspond to 
large differences in precursor ion signal, thus optimization of the DESI source 
parameters can be time consuming. Even under optimal conditions, the signal can 
be nearly 100-fold lower than that achieved with ESI of the same sample. Therefore, 
this method is not recommended for the sn-positional isomeric analysis of low-
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abundance phospholipids. Also, many software suites developed for mass spectral 
imaging are biased towards matrix-assisted laser desorption ionization (MALDI) over 
DESI; sometimes only including data processing methods for MALDI-based images. 
This can make data interpretation more difficult for DESI-based imaging applications. 
In addition, many imaging software suites are not flexible or customizable and do 
not allow for much user-intervention during image processing. This leaves little room 
for accurate image processing for more creative or novel imaging methods like DESI- 
CID/OzID, which makes use of an MS3 scan, where several selected fragment ions 
should ideally be added together or averaged for a more accurate depiction of 
phospholipid sn-positional isomeric distribution. However, as the number of 
multistage mass spectrometric imaging experiments increases, so too will the need 
for improved software to manage multistage mass spectrometric imaging datasets. 
These types of imaging experiments are already providing useful information that 
cannot be obtained by imaging using solely full MS scans only, and so, make use of 
MSn -  this is demonstrated in Chapter 4 and discussed in recent publications.183 As 
this realization becomes more widespread, an opportunity exists for increased 
numbers o f multistage mass spectral imaging datasets to drive the creation of 
powerful yet simple software to manage these datasets.
5.1.2 Biological findings
Using LC-OzID, the analysis of m/z 782 and m/z 808 showed the presence of 
phospholipid isomers for both mass-to-charge ratios. For m/z 782, PC 16:0_18:1 (11) 
and PC 16:0_18:1 (9) were identified while for m/z 808, both PC 18:1 (9)_18:1 (9) and 
PC 18:0_18:2 (9,12) were identified (Chapter 2). The phospholipid, PC 16:0_18:1 (11) 
was found to be less abundant than PC 16:0-18:1 (9) in both egg yolk and sheep 
brain extracts. However, the relative ratio of PC 16:0 18:1 (11) to PC 16:0 18:1 (9) was 
slightly higher in sheep brain extract than in egg yolk extract.
The analysis of mixtures of phospholipid sn-positional isomers alongside 
biological extracts containing mixtures of phospholipid sn-positional isomers using 
DESI-CID/OzID revealed that a wide degree of variation in phospholipid sn-positional 
isomeric composition. DESI-CID/OzID revealed differences in relative isomer
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composition ranging from approximately 50% - 97% for some isomeric pairs across 
different organisms, different tissues and even different regions of the same tissue 
(see Chapter 4). One of the most interesting findings was discovered in lipid extracts 
from the cow eye lens. For these extracts, DESI-CID/OzlD showed that PC 18:1/16:0 
was at least as abundant, if not more abundant, than PC 16:0/18:1. This is interesting 
because, as discussed in Chapter 1, the contemporary scientific literature assumes 
that the unsaturated fatty acid is found predominately at the sn-2 position.56 Another 
interesting finding is the fact that for the phospholipid sn-positional isomeric analysis 
of m/z 782 (PC 34:1), both egg yolk and sheep kidney medulla (but not cow kidney 
medulla) contained a higher purity of PC 16:0/18:1 than the synthetic phospholipid 
standard provided by a commercial vendor as PC 16:0/18:1 (9Z). Also interesting is 
the difference in phospholipid sn-positional isomeric purity for multiple micro­
extractions of two different regions in the same tissue, white matter and grey matter 
of sheep brain. This was later confirmed by DESI-CID/OzlD imaging o f a sheep brain 
tissue section, showing the same trend of increased abundance of PC 16:0/18:1 over 
PC 18:1 /16:0 in white matter than in grey matter.
It is important to remember that even though these biochemical findings are 
reproducible, the sample size used was relatively small consisting of only 1 -  6 
biological replicates and 4 method/spot replicates.
5.2 Future Work
The continuation of this research can go in many directions. LC-OzID could be 
used to profile a wide array of phospholipid double bond positional isomers in 
complex biological extracts. In order to work towards profiling of biological extracts 
at a single structure level, LC-OzID could be used to simultaneously identify acyl 
chain double bond position and sn-position in a single experiment. These 
phospholipid profile datasets could be stored in a searchable, online database. These 
data could be added to a pre-existing online database like LIPID MAPS Lipidomics 
Gateway.184 In order to facilitate doing so, future work to integrate automated mass 
spectral annotation, for instance to label ozonolysis peaks and their corresponding 
double bond position or acyl chain position, into pre-existing software platforms
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would be very useful as currently mass spectra must be manually annotated. This 
automated annotation software or plug-in should be relatively straightforward as the 
neutral losses along with their corresponding double bond position or acyl chain 
position have already been tabulated in Chapter 3 and in a previous publication.167
To work towards this goal, a higher-throughput profiling method should be 
used. For instance, data-dependent LC-OzID and/or LC-CID/OzID scans could be used 
so that multiple phospholipid mass-to-charge ratios may be analyzed in a single 
chromatographic run. Using this approach, a full suite of phospholipid double bond 
positional and sn-positional isomers for a biological extract could be analyzed in a 
single chromatographic run. The limitation for this approach at present is software 
development.
Another approach that could be used for higher-throughput LC-OzID analysis 
of biological extracts that would allow for improved detection, quantification and 
analysis speed of phospholipid isomers during LC-OzID analysis would be to set up 
several successive MS scans followed by a single OzID scan. This approach allows for 
a larger number of MS data points across a peak, thereby allowing for the improved 
detection of subtle chromatographic peak features, like peak shouldering that could 
be indicative of partially-resolved phospholipid isomers. This would lead to improved 
LC optimization for use with OzID. This increase in MS data points across 
chromatographic peaks also renders quantification more accurate by the LC-MS 
scans, especially for fast-eluting or low-abundance phospholipids that result in 
sharper or smaller peaks, while using the more time-intensive OzID scans only 
sparingly for identification. If the current number of data points across a 
chromatographic peak is sufficient, using the LC-OzID method described herein, this 
approach could be used to shorten chromatographic run time while still maintaining 
an acceptable degree of resolution. This approach could also be used with lower flow 
rate chromatography, which typically make use of smaller diameter 
chromatographic columns and can result in sharper chromatographic peaks, which 
would require faster MS acquisition times to maintain the integrity of the apparent 
chromatographic resolution.
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For improved structural identification, LC-CID/OzID could be combined with 
successive scan types so that double bond information can be obtained using the 
online ozonolysis set up on the single-stage ion trap mass spectrometer (Thermo 
Fisher Scientific, LTQ) as well. Double bond position assigned to fatty acids at specific 
sn-positions has been obtained using CID/OzID2 and (CID/OzID)2 with a similar 
instrumental setup,102 However, these methods have not yet been combined with LC. 
This approach could also be used for detailed structural profiling of phospholipids in 
biological extracts.
The ability of DESI-CID/OzID to be used for high-throughput analysis of 
phospholipid sn-positional isomers would be most useful when applied to a large 
sample cohort and/or for which sample volume or availability is limited. In addition, 
not only does DESI save more analysis time the larger the sample size but sample 
carry-over is minimized and sample analysis is more automated when compared to 
using an approach like direct infusion (ESI). This is because DESI does not require 
repeated (manual) washing of a sample syringe between each sample analysis as 
with direct infusion. DESI-CID/OzID could also be used to analyze the phospholipid 
sn-positional isomeric distribution of samples that are present on a surface and 
cannot be easily extracted. Using DESI with CID/OzID, the extraction step may even 
be avoided altogether to save analysis time as well if the sample is already present on 
a fiat surface. Along similar lines, liquid extraction surface analysis (LESA) could also 
be a viable alternative for use with CID/OzID. LESA-MS on arrays of lipid samples has 
previously been described.185 Briefly, samples can be distributed on a surface or in 92- 
well plates. A robotic arm carrying a pipette tip can be directed to the location of the 
sample to deposit a droplet of solvent that remains in contact with the surface to 
extract analytes for a desired length of time. This droplet, now containing analytes of 
interest, is then aspirated into the syringe and introduced into the mass 
spectrometer by means of injection into one of many nanospray emitters on a chip. 
Alternatively, a liquid sample can be directly aspirated from a well in the 92-well 
plate into the pipette tip  and introduced into a nanospray emitter. This would 
represent a small sacrifice in time but would allow for a greater number of scans to 
be averaged or summed, which could greatly improve the signal-to-noise ratio of
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analyte ions, and their diagnostic ozonolysis ions, especially those present at low 
abundance.
DESI-CID/OzlD imaging -  demonstrated here for the first time - could in­
principle be extended to three-dimensional imaging by acquisition of data from 
successive two-dimensional tissue sections.186 Three-dimensional DESI-CID/OzlD 
imaging may aid in understanding the roles of phospholipid isomers in biology as 
well as their associated mechanisms. However, this is not recommended as software 
limitations exist for 3D imaging using DESI as they do with 2D imaging. MALDI 
CID/OzID imaging could also be used to obtain mass spectral images of the 
distribution phospholipid sn-positional isomers with high spatial resolution as well as 
improved sensitivity. Because MALDI is also a soft ionization technique and because 
MALDI sample preparation, instrumental methods and data processing 
considerations have been researched in depth for imaging applications, and would 
make MALDI-CID/OzID analysis more amenable to 3D imaging applications than 
DESI-CID/OzlD.104186188
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6 APPENDIX A: SUPPLEMENTARY MATERIALS FOR CHAPTER 2, COMBINING 
LIQUID CHROMATOGRAPHY WITH OZONE-INDUCED DISSOCIATION FOR THE 
SEPARATION AND IDENTIFICATION OF PHOSPHATIDYLCHOLINE DOUBLE
BOND ISOMERS
ESI
\
Figure 6.1 Schematic of the modified QTRAP 2000 mass spectrometer w ith online 03 
generation used in these experiments.
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Figure 6.2 Results of LC-MS analysis for all detectable ions of a commercially available 
lipid extract from egg yolk.
Total ion chromatograms (TICs) extracted from the full scan mass spectra (i.e.,, Q3 
scans) are shown for two replicate injections (a and b) of egg yolk extract and 
highlight the repoducibility of the method and the complexity o f the sample.
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Figure 6.3 Results of LC-MS analysis of polyunsaturated phosphatidylcholines in a 
purified phosphatidylcholine extract from egg yolk.
Shown above is (a) the region of interest of the chromatogram constructed from 
total abundance of ions detected in OzID scans of mass-selected m/z 804. The OzID 
mass spectra obtained by integrating all scans between across the three 
chromatogtaphic peaks are shown as panels (b)-(d). OzID peaks (labelled with
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brackets) indicate the presence of the isomeric polyunsaturated 
phosphatidylcholines (b) PC 18:2(n-6,n-9)_18:2(n-6,n-9) and (d) PC 16:0_20:4(n-6,n-
9,n-12,n-15). The OzID spectrum obtained from the chromatographic peak eluting at 
16.7 min (c) is consistent with the presence of PC 18:1 (n-9)_18:3(n-3,n-6,n-9) but the 
lower signal-to-noise ratio prevents an unambiguous assignment under the current 
experimental conditions.
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Figure 6.4 OzID spectrum obtained from a PC 16:0/18:1 (n-9) standard using shorter 
reaction times.
OzID spectrum obtained from a PC 16:0/18:1 (n-9) standard using reaction times of 
300 ms (compared to 2000 ms used in the experiments reported herein, cf. Fig. 3). 
Despite the lower signal-to-noise the OzID peaks at m/z 489 and 505 allow the 
unambiguous assignment of the double bond position as n-9.
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Table 6,1 Look-up table for characteristic neutral losses observed in OzID spectra for 
common carbon-carbon double bonds at positions "n-x" w ithin mono-unsaturated 
acyl chains.141,167
double bond position OzID neutral loss to OzID neutral loss to 
(n-x)* form aldehyde ion (Da) form"Criegee ion"(Da)
n-3 26 10
n-6 68 52
n-7 82 66
n-9 110 94
n-12 152 136
* where "x" provides the 1st carbon of the double bond as counted from the methyl terminus
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7 APPENDIX B: SUPPLEMENTARY MATERIALS FOR CHAPTER 3, SEPARATION 
AND IDENTIFICATION OF PHOSPHATIDYLCHOLINE REGIOSOMERS BY 
COMBINING LIQUID CHROMATOGRAPHY WITH A FUSION OF COLLISION- 
AND OZONE-INDUCED DISSOCIATION
36 38 40 42 44 46 48 50 52 54
Time (min)
Figure 7.1 LC-MS analysis of a synthetic standard provided as PC 16:0/22:6.
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These data were acquired with a much higher sample loading than those shown in 
Figure 2.2. (a) Total ion chromatogram for LC-CID/OzID of m/z 828. (b) The CID/OzID 
spectrum obtained from integrating across the chromatographic peak between 44.3­
45.4 min. (c) The CID/OzID spectrum obtained from integrating across the 
chromatographic peak between 46.2-47.3 min. (d) The extracted ion chromatogram 
for CID/OzID product ions at m/z 451 (indicative of PC 22:6/16:0) is shown in green, 
while the extracted ion chromatogram for m/z 379 (indicative of PC 16:0/22:6) is 
shown in blue.
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8 APPENDIX C: SUPPLEMENTARY MATERIALS FOR CHAPTER 4, A RAPID 
AMBIENT IONIZATION-MASS SPECTROMETRY APPROACH TO MONITORING 
THE RELATIVE ABUNDANCE OF ISOMERIC GLYCEROPHOSPHOLIPIDS
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Figure 8.1 Schematic o f the online and offline OzID setups.
Shown above is (a) the schematic illustrating the offline setup for delivery of ozone to 
a modified linear ion-trap mass spectrometer (LTQ Thermo Fisher Scientific, San Jose 
CA, USA), Ozone is generated offline using a HC-30 ozone generator (Ozone 
Solutions, Sioux Center, I A, USA) and collected in a suitable gas tigh t plastic syringe. 
Gas from the syringe is delivered to the helium buffer gas via a PEEKsil restriction 
(100 mm L x  1/16 in. OD x  0.025 mm ID, SGE Analytical Science, Ringwood, Vic, 
Australia). This method, including the safe generation and collection of ozone, is
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described in detail in reference 167. (b) the schematic illustrating the online ozone 
generation and delivery setup for the linear ion-trap mass spectrometer. Ozone is 
generated using a 0.2 L min 1 flow of industrial grade oxygen through an ozone 
generator (Titan 100 generator, Absolute Ozone, Edmonton Canada) and was 
measured at ca. 170 g m 3 (normal) using and inline ozone analyzer (Mini HiCon; 
InUSA Inc., Norwood, MA, USA). Thus formed, a low flow of ozone/oxygen was added 
to the ion trap supply helium buffer gas using a variable leak valve (VSE Vacuum, 
Lustenau, Austria). This method is based on previous developments for online ozone 
generation and delivery for ion-trap mass spectrometers as described in reference140.
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Scheme 8.1 Proposed CID/OzID mechanisms for PC 16:0/18:1 and PC 18:1/16:0.
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Proposed mechanism to account for the CID/OzID product ions observed in the 
spectra shown in Figures 4.2 and 4.3 from (a) [PC 16:0/18:1 + Na]+ and (b) [PC 
18:1/16:0 + Na]+. Mechanisms and product ion structures are based on proposals 
outlined in reference102.
Day-to-day variation in abundance data when using offline ozone generation
Figure 8.2 displays the day-to-day variation for DESI-CID/OzlD measurements 
of synthetic PC 18:1 (9Z)/16:0 and PC 16:0/18:1 {91), and a phosphatidylcholine extract 
from chicken egg yolk. Although the values for the % composition for analogous sn- 
positional isomers does not appear to vary from day to day, for ail 3 samples, the 
values obtained on day 1 fall outside the error bars of those obtained on the second 
day. These data were acquired using "offline" ozone generation and so the variability 
observed likely arises from different ozone concentrations in the ion trap for the 
experiments conducted on different days. As noted in the main body of the 
manuscript, the two sn-positional isomers have slightly different rates of reaction at 
the OzID step in the sequence thus with different ozone concentrations the 
abundance of characteristic ions can vary accounting for the observed day-to-day 
variability in these data. Generating ozone "online" has been shown to provide 
reproducible ozone concentrations.140' 147 Thus the experimental configuration was 
modified as shown in Figure 8.1 to provide a continuous, stable supply of ozone to 
the ion trap.
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Figure 8.2 The abundance of PC 34:1 sn-positional isomers of composition in 
different phospholipid samples over multiple days.
The abundance of sn-positional isomers PC 18:1/16:0 and PC 16:0/18:1 as a 
percentage of phosphatidylcholines of composition PC 34:1 in different biological 
and synthetic samples. Isomer contributions are estimated from the normalised 
product ion abundances in DESI-CID/OzID mass spectra as described in the text. The 
inter-day comparison of composition of sn-positional isomers of PC 34:1 present in 
synthetic standards, PC 16:0/18:1 and PC 18:1/16:0, and an egg yolk 
phosphatidylcholine extract is shown. All data points represent an average of at least 
four technical replicates. Uncertainties shown represent standard deviation. Spectra 
acquired using offline ozone generation (see Methods).
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Comparison o f the relative rates o f reaction o f lipid isomers with ambient ozone
There are several opportunities during sample preparation and analysis for 
unsaturated lipids to be exposed to ambient ozone present in laboratory air. 
Previous studies have shown this reaction can be rapid.179’ 180 It was thus necessary to 
establish whether the sn-positional isomers would have similar or different rates of 
reaction under these conditions as this could alter the relative populations of isomers 
in the sample arrays.
To investigate this effect, the synthetic PC isomers - PC 16:0/18:1(9Z) and PC 
18:1 (9Z)/16:0 - were deposited onto PTFE spots in a sample array and were left on the 
bench for 15, 180 or 1440 mins. Following these intervals the arrays were analyzed 
using DESI-MS in positive ion mode (as described in the Methods section). The 
abundances of ions at m/z 830 corresponding to the lipid ozonide ions, [M+Na+On]', 
were compared to the abundances of the remaining un-reacted lipid at m/z 782. 
Under these conditions formation of ozonides on the surface was found to be 
minimal after an exposure of 15 mins. Given the procedures for sample preparation 
and storage used in this study (see Methods) this suggest a negligible effect on any 
results reported herein.
The data acquired at longer exposure times are summarized in Figure 8.3 and 
show the significant production of ozonides; consistent with prior reports. 
Importantly however, the ozonide production is comparable for the two isomers 
investigated suggesting that ambient ozonolysis will have a negligible impact of 
composition estimates based on DESI-CID/OzID analysis.
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Figure 8.3 Ozonides formed from the reaction of unsaturated lipids deposited with 
ambient ozone.
The abundance of ozonides formed from the reaction of unsaturated lipids 
deposited on PTFE spots with ambient ozone present in laboratory air. Under 
positive ion DESI-MS analysis, ozonides were detected as [M+Na+03]+ ions (m/z 830) 
and are shown as a percentage of the synthetic standards PC 18:1/16:0 or PC 
16:0/18:1 detected as [M+Na]+ ions {m/z 782). All data points represent an average of 
at least four technical replicates. Uncertainties shown represent the standard 
deviation.
132
c
d
PC 18:1/16:0
PC 16:0/18:1
PC 34:1
Figure 8.4 CID/OzID of m/z 782 conducted across a tissue section of a sheep brain.
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A coronal section of the temporal lobe of the left hemisphere of a sheep brain was 
dissected and sliced to a thickness of 30 pm as described in the Methods. A small 
section of the slice was prepared for mounting onto a glass slide and was positioned 
with the sagittal face upwards for analysis and the outermost side of the left side of 
the brain was oriented at the top of the slide, (a) Photographic image of sheep brain 
section used for direct tissue analysis. Images reconstructed from DESI-MS analysis of 
the tissue. The abundance of diagnostic product ions observed in the DESI-CID/OzID 
(782 —» 599 —») spectra acquired at each position are illustrated for (b) m/z 405 and 
421 indicative of the local abundance of PC 18:1/16:0; (c) m/z 379 and 395 indicative 
of the local abundance of PC 16:0/18:1; and (d) and m/z 599 and 615. All 
reconstructed ion images are normalized with the most abundant product ion signal 
detected as 100% and the intensity scale indicated by the darkness of the blue colour 
is shown under each image for all panels. Note that, the line across the sample image 
is due to a software communication error; the sample analysis was restarted from this 
point.
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Table 8.1 Percent Composition for phosphatidylcholine jn-positional isomers in samples of different origin containing phospholipids.
Comparison o f abundance of PC 36:1, PC 36:2 and PC 34:1 sn-positional isomers in biological tissues using DESI CID/OziD. The composition of PC sn-positional isomers present in synthetic 
standards are also included for comparison with tissue extracts. The composition of each sn-positional isomer as a % o f total PC 36:1, 36:2 or 34:1 respectively for each tissue extract is shown 
("average"). The standard deviation ("+/-") is shown directly below each corresponding average. To calculate the standard deviation, different types of replicate measurements were used. For 
all samples, a minimum o f 4 sample spot replicates were analyzed. Biological replicates were as follows: 5 x sheep brain white matter o f temporal lobe, B x sheep brain grey matter o f temporal 
lobe, 3 x left lobe of sheep liver, 3 x medulla of sheep kidney, 3 x perinephric fat o f sheep kidney, 3 x sheep heart ventricle, 6 x cow eye lens core (m/z 782 only, otherwise 1 biological replicate 
used), 1 x left lobe of cow liver, 1 x medulla of cow kidney and 1 x perinephric fat of cow kidney. Sheep brain extracts, cow ocular lens extracts and synthetic standards, PC 16:0/18:1(9Z) and 
PC 18:1(9Z)/16:Q were analyzed on 2 separate days.
s h e e p COW c h ic k e n s y n t h e t ic  s ta n d a r d s
liver kidney brain heart liver kidney eye egg PC 36:1 PC 36:2 PC 34:1
left iobe
perinephric 
medulla , ;
fat
grey
matter
white
matter
ventricle left lobe
perinephric 
medutla t „ 
fat
lens
core
yolk
PC 18:0/ PC 18:1(9 Z)/ 
18:1(9Z) 18:0
PC 18:1 (9Z)/ 
18:1 (9Z)
PC 16:0/ 
18:1(9Z)
PC 18:1(9Z)/ 
16:0
PC 16:0/20:1 average 0.2 0.3 0.9 1.4 4.4 1.1 0.3 0 4  tTi 3.7 0.6 0.3 0.0
(m/z 379,395)+/- 0.3 0.2 l . l 1.2 1.7 1.4 0.2 0.1 1.1 4.8 0.3 0.1 0.0
_  s  PC 20:1/16:0 average 0.1 0.2 1.1 5.6 2.4 0.5 0.2 0.8 0.1 39.6 0.0 0.0 0.0
£  5  (m/z 433, 449)+/- 0.3 0.2 1.3 2.2 2.0 3.8 0.2 0.5 0.3 25.4 0.1 0.0 0.0
2  N PC 18:0/18:1 average 95.1 88.9 90.8 78.3 73.8 90.1 97.1 78.5 95.0 53.6 94.2 87.7 6.1
.§  (m/z 407,423)+/- 2.4 3.4 3.7 5.9 8.6 7.2 0.5 1.6 1.2 28.0 1.7 0.1 0.1
PC 18:1/18:0 average 4.7 10.6 7.3 14.7 19.5 8.4 2.5 20.3 3.8 3.1 5.2 12.0 93.9
(m/z 405,421) -ty- 2.1 3.3 2.9 6.8 9.0 5.4 0.5 2.0 1.6 4.7 1.6 0.2 0.2
PC 18:0/18:2 average 59.2 26.5 47.5 4.2 1.7 51.5 75.3 25.4 22.9 41.2 53.5 0.1
,s  So (m/z 407,423)+/- 13.6 3.9 15.4 2.9 1.6 10.8 3.1 0.3 6.1 23.8 4.6 0.1
$  §  PC 18:2/18:0 average 1.7 1.7 1.9 0.6 0.9 3.7 1.6 2.0 0.0 4.1 1.8 0.4
U  (m/z 403,419)+/- 0.8 1.0 2.2 0.7 0.8 1.1 0.8 0.4 0.0 9.2 0.7 0.1
^  -S  PC 18:1/18:1 average 39.1 71.8 50.6 95.2 97.4 44.8 23.2 72.6 77.1 54.7 44.7 99.8
(m/z 405,421} +/- 14.3 3.9 15.9 2.8 1.9 10.3 2.8 0.6 6.1 25.9 4*9 0.1
PC 16:0/18:1 average 96.8 93.4 81.9 60.3 83.9 94.9 95.5 82.3 96.4 39.1 97.2 79.28 1.85
(m/z 379, 395) +/- 1.0 1.3 11.4 3.4 4.7 1.1 0.8 0.5 1.1 7.5 1.4 3.35 0.43
^  g  PC 18:1/16:0 average 2.4 5.7 16.6 38.8 15.3 4.3 3.1 16.7 2.2 59.4 2.0 19.96 97.42
(m/z 405,421) +J- 0.9 1.2 11.0 3.4 4.8 1.1 0.7 0.4 0.8 7.1 1.2 3.42 0.54
PC 16:1/18:0 average 0.6 0*6 0.9 0.5 0.6 0.6 0.8 0,8 0.7 0.9 0.7 0.65 0.52
-  (m/z 377,393) +/- 0.3 0.3 0.6 0.5 0.6 0.2 0.2 0.1 0.2 0.9 0.2 0.23 0.21
PC 18:0/16:1 average 0.2 0.2 0.6 0.3 0.2 0.3 0.6 0.3 0.8 0.6 0.1 0.11 0.21
(m/z 407,423) +/- 0.2 0.1 0,4 0.2 0.2 0.2 0.1 0.1 0.3 1.0 0.1 0.16 0.10
PC 16:0/18:2 average 85.4
(m/z 379,395) +/- 1.5
rM o  PC 18:2/16:0 average 2.0
£  ®  (m/z 403,419) V - 0.7
U  -K PC 16:1/18:1 average 12.3
*  1  (m/z 377,393) +/- 1.8
PC 18:1/16:1 average 0.2
(m/z 405,421) 47- 0.1
Table 8.2 Comparison of reported % purities for synthetic standards PC 16:0/18:1 and 
PC 18:1/16:0.
Comparing the purity of commercially available synthetic phosphatidylcholines PC 
16:0/18:1 and PC 18:1/16:0 measured in this study with other reports using 
alternative mass spectrometric methods. It should be noted that batch-to-batch 
variation in synthetic preparations may also give rise to some variation in these 
measurements.
Reference Citation Method % Alternate isomer in PC 16:0/18:1
(synthetic impurity)
% Alternate isomer 
in PC 18:1/16:0
(synthetic impurity)
This study 
Ref116
Kozlowski etal. 
Scientific Reports. 
2015
DESI-
CID/OzID
20% 2%
Ref149
Maccarone ef al. 
J. Lipid Res. 2014, 
55, 1668-1677
ion-mobility
separation
13% 1%
Ref149
Maccarone etal. 
J. Lipid Res. 2014, 
55, 1668-1677
pla2
enzyme
assay
13% 3%
Ref149
Maccarone etal. 
J. Lipid Res. 2014, 
55, 1668-1677
CID/OzID 17% 4%
Ref102 Pham etal. Analyst. 
2014, 739,204-214 CID/OzID 17% 3%
r\ £\02 Pham etal. Analyst. CID {+veRef 2014, 739,204-214 and -ve ion 
modes)
21-23% 10-16%
Ref99
Ekroos etal.
J. Lipid Res. 2003, 
44,2181-2192
CID (-ve 
ion mode)
17% 7%
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